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Abstract 
Semi-degradable, Multi-Functional Hydrogels 
for the Repair of Articular Cartilage Defects 
 
Kara Lorraine Spiller 
Anthony Lowman, Ph.D. 
 
Cartilage cannot undergo spontaneous repair because of a lack of access to the 
blood supply, so cartilage defects progressively deteriorate into osteoarthritis. The typical 
approach for tissue engineering is the cultivation of cells on degradable scaffolds such as 
poly(glycolic acid) (PGA).  The cartilage tissue that results from this method integrates 
well with surrounding tissue when implanted into cartilage defects.  However, the 
mechanical and biochemical properties are inferior to healthy cartilage, and the tissue 
eventually degrades.  Poly(vinyl alcohol) (PVA) hydrogels, on the other hand, have long 
been studied for cartilage replacement because of their similar mechanical and material 
properties, but their complete lack of integration with surrounding cartilage as implants 
has impeded their utility.   
 
The combination of the integrative properties of PGA scaffolds with the mechanical 
properties of PVA hydrogels may allow their use as implants. PVA hydrogels were made 
porous through a novel technique of microparticle incorporation. Average pore sizes 
ranged from 60 to 300µm. Cartilage cells could be seeded throughout the porous network 
and induced to develop healthy cartilage tissue.  Since PVA hydrogels are nondegradable, 
the result was a hybrid hydrogel-cartilage construct that may integrate well with 
surrounding tissue.  Moreover, the nondegradable nature of the PVA hydrogel would 
prevent the mechanical properties from diminishing over time, as is the case with 
xiv  
degradable scaffolds.  These superporous, semi-degradable hydrogels were evaluated as 
cartilage replacement materials in terms of their dynamic structure, mechanical 
properties, and swelling properties, over the course of swelling in model osmotically-
conditioned systems.  The hydrogels were then characterized for their ability to support 
cartilage formation by encapsulated cells and the effects of controlled release of growth 
factors to enhance cartilage formation and integration between the hydrogels and the 
surrounding tissue. 
 
The results demonstrate that these PVA-based hydrogels have the potential to effectively 
replace damaged cartilage, because they have similar mechanical and swelling properties 
that are stable over the long-term, and support cartilage formation and integration with 
surrounding tissue.  A novel technique is also described for evaluating the swelling 
properties of biomaterials in a model system that can be applied to many other types of 
biomaterials and tissues.   

1  
 
Chapter 1: Introduction   
Joint pain and immobility due to cartilage damage are the most common forms of 
impairment in middle-aged and older people [1]. Cartilage undergoes limited 
spontaneous repair because of a lack of access to the blood supply, so cartilage defects 
progressively deteriorate into osteoarthritis. Biodegradable scaffolds have been explored 
for the filling of cartilage defects, including polymers such as poly(lactic acid) (PLA), 
poly(glycolic acid) (PGA), and their copolymers (PLGA). Although cells thrive in these 
matrices, the regenerated tissue is far from stiff enough to support physiological loads 
found in the knee joint [2, 3]. Recent research has focused on the use of hydrogels, 3-D 
crosslinked polymer networks swollen with water, to repair damaged cartilage because 
their structure and material properties are very similar to cartilage [4]. The 
microenvironment of hydrogels allows cells to attach in a more similar way to the 
extracellular matrix (ECM) than do unswollen porous polymeric scaffolds, their elasticity 
allows similar transfer of loads, and their high water contents allow efficient nutrient and 
waste exchange [5]. Natural polymers that have been used to construct hydrogels include 
collagen, alginate, and agarose. While these hydrogels promote chondrogenesis, their 
structures are difficult to control and they are too weak to support the loads that are 
typically found in articular cartilage [6]. Hydrogels made of synthetic polymers allow 
much greater control over the composition, structure, and crosslinking density, so their 
properties can be tailored to mimic those of healthy cartilage.  
 
2  
 
In terms of mechanical properties, the most extensively studied hydrogel system by far is 
poly(vinyl alcohol) (PVA). PVA hydrogels are biocompatible, nondegradable and can be 
covalently crosslinked using chemical reactions and irradiation or physically crosslinked 
through freeze-thaw cycling [7]. They have been shown to be similar to cartilage in terms 
of their porous structure [8], mechanical properties [9-13], coefficient of friction [10, 14], 
swelling properties [15, 16], and fluid transport properties [9, 13]. In addition, the 
properties of PVA hydrogels have been shown to be quite stable even after millions of 
fatigue cycles [17].  
 
A significant challenge prevents the use of PVA hydrogels as cartilage replacement 
biomaterials; as implants, they fail to integrate with surrounding cartilage [18-21]. 
Without a strong biomaterial-implant interface, loads are not effectively transferred and 
the surrounding tissue may resorb due to stress-shielding [22]. The lack of integration 
may be in part from swelling changes, but is also a direct result of the fact that cells 
cannot attach to such a hydrophilic matrix as PVA [23]. Tissue-engineered cartilage has 
been shown to integrate better with surrounding cartilage than hydrogels do [24, 25]. 
  
A successful cartilage implant must have sufficient mechanical properties to take over 
physiological loading and must integrate with the surrounding tissue to ensure a 
continuous joint surface (Fig. 1.1). A PVA hydrogel that is porous enough to allow cell 
seeding, with enough adhesiveness to encourage cartilage formation throughout the 
porous network, may combine the mechanical advantages of PVA hydrogels with the 
integrative advantages of tissue engineered cartilage. The first part of this work examines 
3  
 
how the methods of fabrication of PLGA microparticles within PVA hydrogels can 
introduce high levels of porosity, and how the porosity affects the hydrogels’ mechanical 
and swelling properties. The hydrogels’ dynamic materials properties and swelling 
behavior are then characterized over time in model systems. The ability of these 
hydrogels to support chondrogenesis, with analysis of the effects of hydrogel properties, 
is characterized in vitro. Finally, the ability of these hydrogels to function in the 
controlled release of growth factors and their efficacy as cartilage tissue engineering 
scaffolds are evaluated in vivo in a nude mouse model. 
 
These novel, semi-degradable hydrogels may have the requisite mechanical properties to 
provide immediate mechanical support to a cartilage defect in a way that does not 
diminish with time, while promoting integration with the surrounding tissue in order to 
ensure appropriate load transfer (Fig. 1.2).  
4  
 
 
 
 
 
 
 
Figure 1.1. Schematic showing how the combination of PVA hydrogels with PLGA 
scaffolds can have the important properties of a cartilage implant. 
5  
 
 
 
 
 
 
 
Figure 1.2. Implant design strategy. 
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Chapter 2: Background 
2.1. Anatomy of the knee joint 
 
Bones, ligaments, tendons, cartilage, and muscles form the knee, the largest joint in the 
body. Fig. 2.1 shows the major parts of the knee, which work together to form the 
complex joint that withstands stresses several times body weight [26]. These parts act 
synergistically to control the motion, load transmission, and stability of the knee.  
 
The femur and the tibia meet at the knee, and the patella, located in the quadriceps 
tendon, helps to distribute forces between them. The patella slides along the femoral 
groove and has two major biomechanical functions. It increases the lever arm of the 
quadriceps muscle, increasing the force about 30%, and reduces the compressive stress 
on the femur as it transmits force to the tibia by increasing the surface area between the 
patellar tendon and the femur [26]. The patella also increases the moment arm of the 
patellar tendon [27]. The patellar tendon passes from the tibia over the patella and 
becomes continuous with the quadriceps tendon, which joins with the quadriceps 
muscles. These tough fibrous cords are responsible for transmitting forces from the 
muscles to control knee movement [27].  
 
The four major ligaments of the knee are the anterior and posterior cruciate ligaments 
(ACL and PCL) and the medial and lateral collateral ligaments (MCL and LCL). The 
tensile strength of the ligaments and tendons are due to the bundles of collagen fibers and 
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add to the stability of the knee. The PCL is responsible for preventing hyperflexion and 
for limiting posterior movement between the tibia and the femur, and the ACL prevents 
hyperextension and excessive anterior movement, as well as limits excessive internal and 
external rotation [26, 28]. The MCL functions with the ACL to limit anterior translation 
and control external rotation. The MCL is the primary ligament preventing valgus 
deformity, the outward turning of the tibia [26]. The LCL functions secondarily to 
stabilize the knee.  
 
There are two types of cartilage in the knee joint, articular cartilage and the menisci. 
Articular cartilage covers the surfaces of the femoral and tibial condyles, the rounded 
prominence at the end of the bone. It functions as a cushion to protect the bones from 
stress by absorbing energy and transmitting forces between them, as well as providing a 
lubricating surface to reduce friction during movement [29]. Water comprises about 60-
85% of cartilage, depending on tissue depth, which provides the high swelling pressure 
necessary for cartilage to resist compression [30, 31].  
 
The two menisci in the knee are firmly attached with ligaments to the bones, between the 
femoral condyles and the tibial plateau [32]. During flexion, they move posteriorly and 
during extension they move in the anterior direction [26]. Similar to articular cartilage, 
the main function of the menisci is to increase the surface area between bones, thereby 
reducing contact stresses. In addition, they add to the joint’s stability, shock absorption, 
and lubrication [32].  
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2.2. Articular cartilage biology 
2.2.1. Morphogenesis 
 
The initiation of the growth of long bones in embryonic skeletogenesis is characterized 
by the migration, proliferation, and condensation of mesenchymal stem cells and 
subsequent differentiation into chondrocytes [33, 34]. The chondrocytes form a cartilage 
template that will become the developing bone in a process called endochondral 
ossification. Invading capillaries bring perivascular osteoprogenitor cells and recruit 
osteoclasts to degrade the cartilaginous model, which is then replaced by trabecular bone 
[35, 36]. Around the time of birth, the ends of bones contain two cartilaginous structures, 
the growth plate cartilage and articular cartilage, which regulate changes in the joint 
surface during development [30]. As bones continue to grow, the growth plate cartilage is 
replaced by bone and the articular cartilage matures into its permanent structure [30]. 
Interactions among growth factors such as bone morphogenetic proteins (BMP) and 
fibroblast-derived growth factors (FGF) and transcription factors such as Sox9 and 
Runx2 determine whether the chondrocytes remain in the cartilage layer or undergo 
hypertrophy and ossification [33]. The maturation of articular cartilage is influenced by 
mechanical loading, and the characteristic structure and zones are a result of the loading 
history and mechanical environment [30]. 
 
2.2.2. Articular cartilage structure and function 
 
Articular cartilage is a multiphasic tissue consisting of <5% chondrocytes, 60-85% 
interstitial fluid, and a solid extracellular matrix (ECM), composed of about 15-22% type 
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II collagen, 4-7% proteoglycans, and other protein macromolecules [31, 37, 38]. 
Cartilage can be modeled as a material having three layers that are consistent with depth-
dependent variations in the mechanical environment (Fig. 2.2). The superficial layer is in 
contact with the articulating surfaces; collagen fibrils are arranged parallel to the surface, 
fluid flow is high and compressive strains can reach up to 50% [30, 38]. Chondrocytes in 
this layer, subjected to fluid flow and matrix consolidation, are flattened parallel to the 
surface [30]. Chondrocytes in the middle zone experience little strain or fluid flow and 
are loaded primarily under hydrostatic pressure. They are rounded and produce high 
amounts of glycosaminoglycans and type II collagen in random orientation [30]. In the 
deep zone the fibers form thicker bundles that are perpendicular to the joint surface, 
which anchor the cartilage to bone at the tidemark, the transition to calcified cartilage and 
subchondral bone [38]. The cell density in mature cartilage decreases from about 60 
cells/cm3 in the superficial layer to about 10 cells/cm3 in the deep zone, a result of high 
rates of synthesis of extracellular matrix [39, 40].  
 
The mechanical environment of articular cartilage continues to be an important regulator 
of extracellular matrix turnover and remodeling throughout adult life. When joint loading 
is increased above normal levels, the thickness, proteoglycan content, and stiffness of 
cartilage is increased [41, 42], while abnormally low loading causes decreases in 
proteoglycan synthesis and in the thickness of cartilage [43, 44]. Statically applied 
compression causes downregulation of matrix synthesis [45, 46], but cyclically applied 
stresses can cause upregulation of biosynthesis [46]. 
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Mechanotransduction is an important regulator of chondrocyte function [30], and studies 
have shown that chondrocytes respond differently when they are encapsulated within a 
pericellular matrix or not [47, 48]. Chondrocytes interact with their extracellular matrix 
via integrin binding to collagen and fibronectin [49], anchorin CII binding to collagen 
[50], and CD44 binding to hyaluronan [51]. Chondrocytes generally respond to cyclic 
loading in vitro through upregulation of matrix synthesis, which is accompanied by an 
increase in the content of the integrin subunit α5, suggesting a role for integrins in 
mechanotransduction [52, 53].  
 
Moreover, mechanical stimulation is necessary for chondrocyte metabolism and survival. 
Because cartilage lacks blood and lymphatic vessels, nutrient and waste exchange of the 
chondrocytes depend on diffusion and convective transport through the tissue [31]. 
 
2.3. Cartilage biomechanics  
2.3.1. Mechanical properties 
 
Articular cartilage functions as a cushion to protect the subchondral bone from stress by 
absorbing energy and transmitting forces between bones as well as providing a lubricated 
surface to reduce friction during movement [29, 54]. Cartilage is a viscoelastic, 
anisotropic material capable of withstanding stresses of up to 20 MPa and up to 10 times 
body weight during daily activities such as walking [30, 31, 55, 56]. Periods of cyclic 
loading are interspersed with periods of partial and full recovery [30]. After deformation 
under load, cartilage exhibits time-dependent, near complete recovery [54, 57]. 
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The behavior of cartilage in compression and tension is nonlinear and the tangent moduli 
increase with strain rate and magnitude. The behavior of cartilage in unconfined 
compression best represents the in vivo behavior of cartilage in the superficial zone 
because of high strains and fluid flow and low stresses [30]. The elastic modulus of 
human cartilage determined in unconfined compression is 0.4-0.8 MPa [58, 59]. The 
shear modulus, a measure of the intrinsic viscoelasticity of the solid cartilage matrix, 
ranges from 0.20 to 0.40 MPa [31]. 
 
Cartilage is highly hydrated with pores on the order of 1 to 2µm [60]. During loading, 
this interstitial fluid flows through the pores and is resisted by a drag force due to 
association of the water with the charged proteoglycans. Thus, cartilage has a low, strain-
dependent permeability and high resistance to compression [31]. 
 
In 1980, Mow et al. developed a biphasic constitutive theory to describe the flow-
dependent viscoelastic behavior of cartilage in compression [61]. The biphasic theory is 
based on the assumptions that the solid matrix is elastic, porous, and permeable; that the 
matrix and interstitial fluid are incompressible, so that any volume change is a result of 
fluid exudation, which is described by the permeability parameter; and that frictional drag 
of the fluid is the dominant mechanism of viscoelasticity. From this theory, the creep 
behavior of cartilage in confined compression can be described by the equation: 
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                    (2.1) 
 
where HA is the aggregate modulus, k is the permeability, u is the creep displacement, f0 
is a stress parameter and αo0 is the solid content. The equilibrium compressive modulus 
of cartilage, determined from the biphasic theory, is 0.3-1.5 MPa, and the permeability is 
1-10 x10-14m4/Ns [31, 61]. 
 
The behavior of cartilage in creep is described reasonably well by the biphasic theory, but 
other models have been proposed since then to more fully characterize the compressive 
properties of cartilage. The biphasic poroviscoelastic theory describes the behavior of 
cartilage in an indentation test [62]. The triphasic theory extends the biphasic theory to 
include an ion phase, so that part of the compressive stress is supported by the osmotic 
pressure of the tissue [63].  
 
Fluid flow through the matrix also determines the lubricating properties of cartilage. In 
the squeeze-film model of lubrication, fluid that is exuded from the cartilage matrix is 
directed to the gap between the articulating surfaces so that they glide on a thin film [60]. 
This method of lubrication is aided by the pore structure of cartilage, which directs flow 
towards the contact region [60]. In low velocity and high load friction, the boundary 
lubrication mechanism dominates, in which contact during sliding of macromolecules on 
the surface, such as hyaluronic acid, lubricin, and other lipids, reduce friction [60]. The 
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evolving pore structure of the deforming cartilage matrix also contributes to changes in 
lubricating mechanisms. As a result of these mechanisms of fluid flow through pores and 
the presence of lubricating proteins, cartilage has a very low coefficient of friction of 
around 0.005-0.04, akin to ice skates on ice during speed skating [31, 64].  
 
2.3.2. Osmotic pressure 
 
The load-bearing properties of articular cartilage result from the osmotic swelling 
pressure exerted by the concentration of proteoglycans in a large amount of water [65, 
66]. Electrostatic forces between the large, aggregated proteoglycans resist compression 
and help maintain tissue hydration [38, 67, 68]. The high swelling pressure of cartilage 
and other tissues is due to a combination of the concentration-dependent osmotic pressure 
that is characteristic of polymer solutions and the ionic contribution, according to Gibbs-
Donnan equilibrium [65]. This second component of osmotic pressure is the major 
contributor in cartilage, and is due to the negatively charged groups in chondroitin sulfate 
and keratin sulfate [69]. The ionic contribution alone can reach 2.5atm in hip and knee 
cartilage, depending on tissue depth [65, 69]. This high swelling pressure is balanced by 
the collagen network, which limits hydration to a very narrow range, even when the 
tissue is immersed in hypotonic or hypertonic solution [66, 70]. This property of the 
collagen network also ensures that the tissue does not swell or shrink in the body with 
changes in proteoglycan content or applied pressure [66]. Although the water content is 
increased in osteoarthritic cartilage, when the collagen network is damaged, the osmotic 
pressure remains high [65]. 
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2.4. Cartilage damage 
 
Cartilage damage and cartilage-related diseases are the most common cause of disability 
in the United States today, occurring in approximately 6% of people of 30 years of age 
and older, at a cost to the economy of $128 billion [71-73]. The prevalence of arthritis is 
projected to reach 25% of the population, or 67 million people, by the year 2030, as a 
result of the aging population and the obesity epidemic [74].  
 
Cartilage damage can begin as a focal defect or fissure resulting from overloading, 
mechanical injury, or normal wear and tear, and often leads to the debilitating disorder 
osteoarthritis, a degenerative joint disease that results in irreversible loss of structure and 
function of the cartilage [71]. The early stages of osteoarthritis are characterized by clefts 
and fissures in the cartilage that do not extend into the subchondral bone. These partial-
thickness defects do not heal and eventually progress into larger defects [75]. Full-
thickness or osteochondral defects, which extend into the vascularized subchondral bone, 
have some degree of spontaneous repair because of contact with mesenchymal progenitor 
cells, but the repair is transient and the new tissue is functionally inferior to healthy 
cartilage [75-77]. Despite poor outcomes of spontaneous repair of full-thickness defects, 
recapitulation of this event remains the underlying rationale for most of the surgical 
treatments of osteoarthritis [78]. 
 
15  
 
2.5. Current treatments 
2.5.1. Surgical techniques 
 
Surgical techniques that are still in practice to deal with a cartilage defect include 
articular debridement, subchondral microfracture and joint lavage to extend the defect 
further into the bone marrow in order to stimulate reparative stem cells (Fig. 2.3) [79-81]. 
The stem cells differentiate into chondrocytes and fill the defect with fibrous cartilage 
tissue. Besides their highly invasive nature and long recovery time, these techniques fail 
to produce tissue that is biologically or functionally equivalent to healthy cartilage, 
resulting in failure after about 18 months [82, 83]. 
 
Another available treatment is transplantation of grafts of cartilage from non-weight-
bearing regions of the knee, which has had some success, but has considerable 
disadvantages, such as a limit to the defect’s size, damage to the donor site, regional 
differences in cartilage properties, and limited integration [84]. Also, cell viability of the 
graft is reduced when it is exposed to high temperatures during drilling and to metal-ion 
contamination when it is punched out, and when it is stored at very low temperatures and 
subsequently thawed [85, 86]. 
  
Another treatment is osteotomy, in which the thigh bones are reshaped and repositioned 
to remove weight from damaged tissue. Osteotomy relieves symptoms temporarily, but 
does not heal the damaged cartilage, so future surgeries are often required, such as total 
or partial knee arthroplasty [87]. Arthroplasty is the creation of an artificial joint, 
replacing the damaged joint with a prosthesis. Following the major surgery, pain is 
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significantly reduced, but the prosthesis may become loosened or painful over time, and 
is not recommended for younger patients [88]. 
 
Because these treatments do not heal the damaged cartilage, they can only temporarily 
relieve pain and cannot adequately restore mechanical function. A technique is needed 
that can stimulate the generation of functional tissue that can be remodeled by the body 
with growth. 
 
2.5.2. Autologous chondrocyte Implantation (ACI) 
 
The most successful technique that is currently available is autologous chondrocyte 
implantation (ACI), in which a patient’s chondrocytes are isolated from a biopsy from a 
less weight-bearing area of the knee, and expanded in vitro before injecting back into the 
defect under a periosteal flap (Fig. 2.4) [89]. Due to the delicacy of the procedure, ACI is 
often not possible in some regions of the knee [90]. Most patients report improved pain 
scores after ACI, but since the cell mass cannot support loads, patients are prevented 
from full weight-bearing for eight to twelve weeks [89, 91]. Moreover, the repair 
cartilage is still inferior to healthy cartilage, probably related to the fact that chondrocytes 
senesce with age and de-differentiate during expansion [89, 91, 92]. The procedure also 
has several disadvantages and complications, such as separation of the graft from 
surrounding cartilage and periosteal hypertrophy, resulting in repetition of surgery in up 
to 36% of the patients [93, 94]. Furthermore, some studies have shown that the clinical 
outcome of ACI is no better than microfracture or graft transplantation [95, 96].  
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To overcome the technical limitations associated with ACI, cartilage tissue engineering 
grafts were developed to combine the regenerative potential of chondrocytes with the 
stability of three-dimensional scaffolds. These grafts can thus be implanted in minimally 
invasive surgeries or arthroscopically and hold chondrocytes in the cartilage defect 
without the use of a periosteal flap [97]. The use of 3-D scaffolds also promotes the 
chondrogenic phenotype of the cells, which typically de-differentiate when expanded in 
monolayer culture [98-100]. Collagen scaffolds were among the first matrices studied in 
clinical trials for the filling of cartilage defects. At a five-year follow-up, 8 of 11 patients 
reported improvement in knee function [101]. However, when this procedure was directly 
compared to classical ACI, there were no statistically significant differences in 
arthroscopic and histological assessments, and the rate of repeated procedures was 9% in 
each group [102]. 
 
BioSeed®-C is a composite scaffold based on fibrin and poly(glycolic acid)/poly(lactic 
acid) that is purported to have better mechanical properties than collagen gel matrices, 
although limited mechanical characterization was reported [90]. In a two-year clinical 
trial, patients reported decreased pain and there was no evidence of implant loosening. 
Defects were filled with a mix of hyaline and fibrous cartilage that integrated well with 
surrounding tissue, although holes in the tissue were apparent. The quality of the repair 
tissue was not directly compared to other treatments, such as classical ACI, although the 
BioSeed-C failure rate (~3%) was lower than reported failure rates for ACI (~13%) [93]. 
Repair of full-thickness defects in horses using a similar approach resulted in the 
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generation of tissue that scored higher histologically but not biochemically or 
functionally compared to sham surgeries with untreated defects [103]. 
 
Hyalograft®-C is a graft composed of chondrocytes grown on a scaffold made of 
HYAFF®11 (Fidia Advanced Biopolymers, Abano Terme, Italy), an esterified derivative 
of hyaluronic acid [104, 105]. HyalograftC can be implanted into most cartilage defects 
without any fixation methods. Patients reported a statistically significant increase in joint 
function from the pre-operative assessment, and 65% of the patients reported no 
limitations in activity after an average follow-up time of 38 months. Histological analysis 
of 22 biopsies showed that about half of the repair tissues were hyaline-like, and the 
others were fibrocartilage or a mix of fibrocartilage and hyaline-like cartilage. Two of 
141 treatments were considered failures, with very poor defect filling and integration 
with surrounding tissue [104]. 
 
These early tissue engineering strategies, while encouraging, do not show significant 
improvements over traditional treatments, raising questions over cost-effectiveness [101]. 
Patients are generally prevented from any weight-bearing for 4 weeks, and no more than 
15% weight-bearing for 7 to 12 weeks [97, 105]. Current research attempts improve upon 
this method by focusing on biomaterial design to augment and accelerate the formation of 
functional cartilage tissue. 
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2.6. Cartilage tissue engineering 
2.6.1. Biodegradable scaffolds 
 
Matrices have been used as delivery systems for chondrocytes, mesenchymal stem cells, 
and perichondrial cells from the surface of cartilage, in order to confine cells and growth 
factors within the scaffold, and to provide some mechanical support. Biodegradable 
polymers, such as the polyesters poly(lactic acid), poly(glycolic acid), and their co-
polymers, have been used to form scaffolds, so that they degrade as the new tissue forms. 
As early as 1991, chondrocytes embedded in these polymer matrices exhibited repair that 
was mildly successful; the cells proliferated but the biochemical and mechanical 
properties of the new tissue did not match those of cartilage [106]. Cartilage has also 
been formed in these scaffolds by chondrogenically induced mesenchymal stem cells, and 
the tissue integrated well with surrounding tissue upon implantation into non-weight-
bearing areas in the knees of pigs [107]. The compressive modulus of the repair tissue 
reached 80% of that of normal cartilage after 6 months, and biochemical composition was 
comparable, but these results have not been repeated in weight-bearing areas. The rate of 
scaffold degradation is an important factor in the success of polyester-based scaffolds for 
cartilage tissue engineering [3]. Cracks and discontinuities can form if the scaffold 
degrades at a different rate than the new tissue forms [3, 78, 108]. Their degradation 
byproducts also elicit an acute inflammatory response following implantation into the 
body, and may exacerbate an already inflamed area [109, 110].  
 
Natural scaffold materials that have been explored for the filling of cartilage defects in 
clinical trials include collagen and hyaluronan. Because these polymers are naturally 
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occurring components of the cartilage extracellular matrix, they favor cell attachment, 
proliferation, and integration with surrounding tissue [108, 111]. The quality of 
engineered tissue depends on the properties of the collagen scaffold. Chondrocytes 
seeded on type II collagen scaffolds produced higher levels of cartilage tissue than those 
in type I collagen scaffolds [112, 113]. Pfeiffer et al. [114] determined that the degree of 
glycosaminoglycan production by chondrocytes in carbodiimide-crosslinked collagen 
scaffolds was proportional to the resultant compressive modulus of the engineered tissue, 
and varied inversely with the crosslinking density of the scaffolds. The compressive 
moduli of the stiffest constructs were 10% of the value of healthy cartilage [114]. 
Chondrocyte-seeded collagen scaffolds repaired cartilage defects in rabbits after 24 
weeks, resulting in tissue that was biochemically similar to normal tissue [115]. 
However, the mechanical properties of the repair tissue were subpar, and long-term 
results were not reported [115]. In general, collagen scaffolds or tissue engineered on 
collagen scaffolds lack the mechanical properties to withstand loads found in the knee.  
 
Scaffolds composed of hyaluronic acid have several key advantages as a biomaterial for 
cartilage repair. Hyaluronans are found in abundance in cartilage extracellular matrix and 
synovial fluid, and play a critical role in maintaining the lubricating properties of the joint 
[116]. Intra-articular injections of hyaluronan can also relive symptoms of osteoarthritis 
and slow disease progression [117]. Bone marrow was obtained during the generation of 
osteochondral defects in rabbits, combined with hyaluronan sponges, and implanted back 
into the defects in the same surgery [118]. The progenitor cells in the bone marrow 
differentiated into bone and cartilage in the correct areas of the osteochondral defect, and 
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the newly formed tissue was well-integrated with the surrounding tissue [118]. 
Hyaluronan scaffolds were directly compared to poly(lactic acid) and poly(lactic-co-
glycolic acid) scaffolds in the repair of osteochondral defects in rabbits [3]. Repair tissue 
formed more quickly in hyaluronan-based scaffolds, presumably because of the 
biological cues provided by hyaluronan that are not present in the synthetic scaffolds [3].  
 
Purified silk from Bombyx mori has been used for decades as sutures, and scaffolds can 
be made from silk by pressing the natural or electrospun fibers into meshes, inducing a 
sol-gel transition of aqueous silk solutions to form hydrogels, or drying aqueous solutions 
in the presence of porogens into porous scaffolds [119]. Scaffolds prepared using the salt 
leaching technique have similar compressive moduli to cartilage, and have been shown to 
support chondrogenesis by encapsulated MSCs [120]. Silk scaffolds are degraded 
proteolytically through the action of enzymes secreted by encapsulated cells over the 
course of 1-2 years [119]. However, silk scaffolds do not swell or retain water like 
cartilage [120]. Since the mechanical properties of cartilage stem from its high swelling 
pressure and fluid flow, non-swollen porous scaffolds can never recapitulate the 
chondrocytes’ environment.  
 
2.6.2. Hydrogels for cartilage tissue engineering 
 
Cartilage is composed of long-chain polymers of glycosaminoglycans and collagen 
swollen in a large amount of water, making it essentially a hydrogel [15]. Hydrogels are 
3-D hydrophilic polymer networks that are highly swollen in water, so their structures 
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and mechanical properties are more similar to native tissue [16]. Since the development 
of methacrylate-based gels for biological applications in the early 1960s [121], hydrogels 
have since been utilized in drug delivery, surface modification of biomedical implants, 
diagnostic devices, and tissue engineering of a slew of tissue types. The material 
properties of hydrogels can be tailored by varying parameters such as polymer 
composition, crosslinking density, network morphology, and degradability [122]. 
 
Hydrogels have thus been used alone to replace damaged cartilage and/or recruit host 
cells to the defect site, and as cell carrier materials that encourage cellular remodeling 
and tissue generation. As cell-free implants, hydrogels are structurally and can be 
mechanically similar to cartilage and allow efficient load transfer [9, 14]. As cell-seeded 
tissue engineering scaffolds, hydrogels are also extremely useful: they promote 
chondrocyte attachment in a manner that is similar to the cartilage ECM [123]; they 
maintain the chondrocyte phenotype in a way that is impossible in monolayer culture 
[124-126]; and their elastic nature permits effective transfer of loads to the chondrocytes 
which depend on mechanical signals for survival [127, 128]. 
 
Hydrogels can be composed of naturally-derived materials, such as agar and collagen, or 
of synthetic polymers like poly(ethylene glycol) (PEG) and poly(vinyl alcohol) (PVA), 
and can be physically, ionically, or covalently crosslinked.  
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2.6.2.1. Naturally-derived polymers 
 
Hydrogels formed from naturally-derived polymers are attractive biomaterials because 
they are biochemically similar to tissues and naturally degraded by cell-secreted 
enzymes. Hydrogels can be prepared from proteins such as collagen and fibrin and from 
polysaccharides such as agarose, alginate, chitosan, and hyaluronan. Agarose and alginate 
were among the first hydrogels studied for tissue engineering due to ease of cell 
encapsulation, but the lack of mechanical properties or structural control make them less 
favorable for cartilage tissue engineering [125, 129]. 
 
Hydrogels can be formed from collagen by spontaneous gelation or chemical crosslinking 
using aldehyde or carbodiimide chemistry [130]. Collagen hydrogels are biomimetic, 
have high swelling ratios, and promote cartilage formation by encapsulated cells [125]. In 
1994, the landmark study by Wakitani et al. reported that mesenchymal stem cells 
embedded in collagen gels repaired cartilage defects in rabbits, filling them with hyaline 
cartilage [131]. However, the mechanical properties of the regenerate still failed to match 
normal cartilage, and by 24 weeks, the repair tissue had thinned and there were areas of 
incomplete integration. Indeed, the lack of mechanical integrity led to failure of collagen 
gels as cell-seeded implants in cartilage defects in a longer-term canine model [132]. In 
fact, many animal studies involving cells seeded in collagen gels are characterized by 
short-term success followed by implant failure [133]. Although collagen gels are an 
integral component of matrix-assisted ACI [102], they are far too weak to support 
physiological loads. They degrade in about 2-3 weeks [130, 134], which is too fast to 
generate cartilage that can withstand compressive loads. Collagen gels also have high 
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levels of variation among batches and can be immunogenic [125, 135, 136]. Collagen 
gels have nonetheless been useful in studying the behavior of chondrocytes and stem 
cells in vitro under various conditions [137-140].  
 
Scaffolds based on hyaluronan are already used clinically in HyalograftC for ACI [104], 
but technological advances in the design of hyaluronan hydrogels offer more control over 
design parameters. Photocrosslinkable hyaluronan hydrogels are formed by the addition 
of a methacrylate group to the hyaluronan backbone and subsequent crosslinking in the 
presence of water by optical trigger [141]. Chondrogenesis of mesenchymal stem cells 
was enhanced in comparison to biologically inert poly(ethylene glycol) hydrogels, 
emphasizing the role of biochemical cues in tissue engineering strategies [142]. The 
degradation rate of hyaluronan hydrogels, which are degraded by cell-secreted 
hyaluronidase, was modified through the addition of hydrolytically degradable units 
[143]. A balance existed between a degradation rate that was fast enough to allow room 
for newly synthesized extracellular matrix components and a rate that was slow enough 
to sufficiently retain the proteins [143]. Control over hydrogel degradation also allows 
control over nutrient and waste diffusion in a growing cartilage construct [144]. 
 
Chitosan is prepared by partial N-deacetylation of chitin, derived from the exoskeleton of 
arthropods, and is structurally similar to the glycosaminoglycans found in cartilage (Fig. 
2.5). The gelation of chitosan can be induced by ionic or chemical crosslinking [145, 
146]. The kinetics of degradation of chitosan by cell-secreted lysozyme can be controlled 
through hydrogel properties such as crystallinity and degree of acetylation [147, 148]. 
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Although there have been relatively few in vivo studies of chitosan hydrogels in repairing 
cartilage defects, there has been interesting work regarding chemical modification of 
chitosan to make an injectable scaffold [149-152] and to increase its biochemical 
similarities to cartilage [149, 153-155]. The structural similarity of chitosan to natural 
components of the cartilage extracellular matrix makes it a promising technology for 
cartilage tissue engineering. 
 
The lack of control over structural and mechanical properties and potential 
immunogenicity of naturally-derived hydrogels have led to the investigation of hydrogels 
composed of synthetic polymers. 
 
2.6.2.2. Hydrogels based on poly(ethylene glycol) (PEG) 
 
The use of synthetic polymers to prepare hydrogels allows a great deal of control over the 
structural, mechanical, and swelling properties, which has led to detailed investigations 
into the effects of hydrogel properties on cartilage formation. The most commonly 
studied hydrogels for cartilage tissue engineering are those based on poly(ethylene 
glycol) (PEG), also known as poly(ethylene oxide), owing to its ease of chemical 
modification and cell encapsulation. PEG hydrogels, modified with methacrylate groups 
to allow photo-crosslinking, were first introduced by Elisseeff et al. as an injectable and 
transdermally photopolymerizable hydrogel for cartilage tissue engineering [156]. 
Chondrocytes, mesenchymal stem cells, and embryonic stem cells have been 
encapsulated in these hydrogels and induced to form cartilage tissue [156-158]. 
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Mesenchymal stem cells were mixed with the polymer solution and injected 
subcutaneously into nude mice, and the hydrogels were crosslinked by the application of 
UVA light through the skin [157]. The stem cells differentiated into chondrocytes and 
produced cartilage tissue when either TGFβ3 or hyaluronic acid was co-encapsulated 
with the cells [157].  
 
PEG macromers were also modified with hydrolytically labile poly(lactic acid) (PLA) to 
allow biodegradation (Fig. 2.6) [159]. Hydrogels with higher percentages of degradable 
moieties supported production of higher amounts of extracellular matrix components by 
encapsulated chondrocytes, which was attributed to enhanced diffusion [160]. Hydrogels 
with higher swelling ratios allowed a more homogenous distribution of 
glycosaminoglycans than hydrogels with lower swelling ratios [159]. The concentration 
of macromer in the hydrogels also affected cartilage formation [161, 162]. Finally, the 
effects of mechanical properties on encapsulated hydrogels were investigated. By 
changing the crosslinking density, the elastic modulus of the hydrogels was varied, and 
the highest levels of extracellular matrix synthesis were observed in hydrogels with a 
compressive modulus that was similar to native cartilage [159].  
 
Control over the properties and functionality of PEG hydrogels was further increased by 
copolymerizing PEG-PLA with multivinyl poly(vinyl alcohol) (PVA), which allowed the 
addition of various substituents due to its plethora of pendant hydroxy groups [6]. 
Changes in the macromer chemistry and functionality affected the hydrogel properties. 
For instance, increases in PVA content reduced the compressive moduli and increased the 
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degradation rates of the hydrogels [6]. When chondrocytes were encapsulated in these 
hydrogels by photopolymerization, cartilage tissue formed in vitro over 6 weeks and was 
homogenously throughout the hydrogels [6]. 
 
The degradation of PEG hydrogels has also been varied by crosslinking with 
biodegradable genipin [163], matrix-metalloproteinase-sensitive peptides [164], 
phosphate-releasing groups [165], and by combining with dextran-based hydrogels [166]. 
The PEG macromer has also been modified with fumaric acid to form new hydrogels 
made of oligo(poly(ethylene glycol) fumarate) (OPF), which are photocrosslinkable and 
injectable [167]. These hydrogels, which can be prepared with compressive moduli as 
high as cartilage, have also been used to evaluate the effects of the controlled release of 
various growth factors on cartilage formation in vitro and in vivo [167-169]. 
Mesenchymal stem cells that were encapsulated in OPF hydrogels differentiated into 
chondrocytes and produced cartilage tissue in vitro [170]. 
 
PEG macromers have also been modified with moieties that make the hydrogels more 
biomimetic in some way. The addition of collagen-mimetic peptide, or –(Pro-Hyp-Gly 
)x—, resulted in enhanced retention of cell-secreted collagen and increased production of 
both collagen and proteoglycans by chondrocytes [171]. The incorporation of chondroitin 
sulfate into PEG hydrogels resulted in increased expression of chondrogenic markers by 
mesenchymal stem cells and downregulated expression of collagen X, indicating that 
chondroitin sulfate moieties inhibit hypertrophy of stem cells towards the bone lineage 
[172]. 
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Hydrogels have the capacity to encapsulate chondrocytes or mesenchymal stem cells in a 
way that is more similar to native cartilage than porous scaffolds. However, the 
mechanical properties of poly(vinyl alcohol) (PVA) hydrogels more closely mimic native 
cartilage than other materials. 
 
2.7. Poly(vinyl alcohol) (PVA) hydrogels 
 
In 1973, Bray and Merrill were the first to suggest the possibility of using synthetic 
hydrogels as cartilage replacements, describing the structural and mechanical similarities 
between cartilage and PVA hydrogels [11]. Aqueous solutions of PVA can be chemically 
crosslinked into hydrogels through the formation of acetal linkages using difunctional 
crosslinking agents like formaldehyde and glutaraldehyde or by electron beam or gamma 
irradiaton [122]. PVA hydrogels can also be physically crosslinked through the formation 
of crystallites during annealing and dehydration, freeze-thaw cycling, or by phase 
separation from theta-solutions [16, 173-175].  
 
PVA hydrogels prepared by freezing and thawing retain the size and shape of the mold in 
which they are prepared, making them very useful for tissue engineering applications. 
The method of PVA cross-linking is attributed to the crystallization of highly 
concentrated regions of aqueous PVA, which form as water freezes. Crystallites form in 
the PVA phase and hydrogen bonds form between chains, resulting in a three-
dimensional hydrogel network that is essentially insoluble in water [176-178]. The 
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crystallites increase in size and the density of the gel structure increases with each 
freezing and thawing cycle, causing increasing mechanical strength [16, 174, 179]. 
 
Like cartilage but unlike most other hydrogels, PVA hydrogels are stiff yet retain high 
water contents and swelling ratios. They have been used as model systems to study the 
lubricating and swelling properties of articular cartilage [15, 180]. The mechanical 
properties of PVA hydrogels are dependent on their properties such as method of 
crosslinking [14], water content [10, 13, 181], and surface properties [12]. Hydrogels 
prepared by the theta-gel method that had lower water contents had higher compressive 
moduli but lower compressive failure stresses [9]. Similarly, hydrogels prepared by the 
freeze-thaw method with lower water contents exhibited less wear after 100,000 cycles of 
fatigue [10]. PVA hydrogels have been extensively characterized and compared to 
articular cartilage in terms of their mechanical, fluid flow, and frictional properties.  
 
PVA hydrogels are viscoelastic, exhibiting nonlinear and time-dependent behavior in 
compression. Values of compressive modulus measured in unconfined compression, 
shear modulus measured in torsion, and failure strain measured as the point of plastic 
deformation, for PVA theta-gels were similar to human articular cartilage [9]. Their 
compressive moduli, evaluated tangent to the stress-strain curve, increase with both strain 
magnitude and rate, behavior that is similar to articular cartilage [9]. The Young’s moduli 
determined in tension for hydrogels prepared by freeze-thaw or by injection molding 
were also similar to normal articular cartilage [14]. Because the shear moduli of the 
hydrogels were not dependent on strain rate, fluid flow was determined to be the 
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dominant contributor to time-dependent behavior, as opposed to the solid matrix, which 
is also consistent with the behavior of cartilage [9]. This conclusion is further supported 
by the high Poisson’s ratios for freeze-thawed PVA hydrogels, which were about 0.73-
1.3 and within the range reported for cartilage [13]. The elastic modulus of the surface of 
PVA hydrogels, measured using atomic force spectroscopy, was similar to cartilage when 
the hydrogels were treated with hyaluronic acid to mimic the lubricating layer of cartilage 
[12]. 
 
PVA hydrogels also have similar frictional and lubricating behavior to articular cartilage, 
directing fluid to contact surfaces according to the ‘squeeze-film’ lubrication model 
under low loads and the ‘boundary’ lubrication model under high loads, with similar 
coefficients of friction [19, 60, 180, 182]. The frictional properties of the hydrogels are 
dependent on the polymer content of the hydrogels, the applied load, and the type of 
lubricant [10, 183, 184]. In ring-ring friction tests of PVA hydrogels prepared by freeze-
thaw cycles and by injection molding articulating against normal articular cartilage, the 
coefficients of friction for PVA hydrogels were not different from normal cartilage [14]. 
In a pin-on-disk test in which PVA hydrogels prepared by drying and rehydration were 
articulated against metal, the average coefficient of friction of the hydrogels was 0.03 in 
the presence of synovial fluid as a lubricant [10], similar to articular cartilage, which has 
coefficient of friction in the range of 0.0005-0.04 [60]. The hydrogels also showed no 
signs of wear on the articulating surfaces after 100,000 cycles of fatigue [10].  
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Some work has indicated that physically crosslinked PVA hydrogels may not be stable in 
vivo because PVA is a semicrystalline polymer that can undergo dissolution as chains in 
the crystalline regions unfold layer by layer [185, 186]. Thomas et al. showed that the 
addition of small amounts of poly(vinyl pyrrolidone) (PVP) stabilized the hydrogel 
network through hydrogen bonding between the hydroxyl groups of PVA and the 
carbonyl groups of PVP (Fig. 2.7) [187]. Hydrogels were prepared from polymer blends 
of PVA and 0.5 to 75% PVP by annealing followed by two cycles of drying and 
rehydration. After 120 days of swelling in water, the minimum dissolution (2.8%) was 
seen for hydrogels prepared with 99% PVA and 1% PVP [187]. Higher amounts of PVP 
sterically interrupted PVA crystallite formation, resulting in greater network instability 
and mass loss during swelling [187]. 
 
One disadvantage of PVA hydrogels is that they are generally not in situ forming, and 
harsh manufacturing techniques prevent the addition of cells prior to crosslinking. PVA 
hydrogels must therefore be rendered porous in order to seed cells. PVA hydrogels have 
also been modified with methacrylate groups to allow photoencapsulation of cells and 
with chondroitin sulfate for biochemical similarity to cartilage as well as biodegradability 
by chondroitinase [188]. Depending on the concentration of PVA, the compressive 
moduli ranged from 5 to 2600 kPa, allowing mechanical similarity to cartilage. 
Encapsulated chondrocytes maintained their spherical morphology over 3 days in vitro 
[188].  
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A disadvantage of all synthetic hydrogels is that they are too hydrophilic to allow protein 
adsorption or cell attachment [23, 189, 190], so hydrogel implants are unlikely to 
integrate with surrounding tissue. When PVA hydrogels were implanted into cartilage 
defects in rabbits or dogs, although there were minimal inflammatory reactions, there was 
also no integration between the hydrogels and the surrounding tissue [18, 19, 191]. 
Despite this challenge, clinical trials of a PVA hydrogel called SaluCartilage 
(SaluMedica, Smyrna, GA) for the repair of discrete cartilage defects were conducted in 
Europe [20]. The hydrogels, which had water contents of about 20%, were press-fit into 
49 stage IV chondral lesions in 18 patients. Although initial results were positive, the 
average McDermott knee scores decreased after 12 months, and the hydrogel implants 
were surrounded by fluid. The authors attributed the failures to dislocation due to 
inadequate fixation to surrounding tissue [20]. 
 
The mechanical and frictional properties of a cartilage implant can be perfectly 
biomimetic, but if it does not integrate well with the surrounding tissue, loads cannot be 
transferred effectively, and new defects will form around the periphery of an implant. 
 
2.8. Integration with surrounding tissue 
 
Attempts at integrating hydrogels with either the bone or cartilage in an osteochondral 
defect have been mechanical, chemical, or biological. Oka et al. have focused on the 
integration of PVA hydrogels with the subchondral bone in order to anchor an implant in 
place [191, 192]. Composites of PVA hydrogels as the artificial cartilage phase and a 
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titanium fiber mesh to anchor into the subchondral bone were implanted into full-
thickness defects in weight-bearing areas in the femoral condyles of dogs [191]. 
Abundant bone ingrowth was observed in the titanium mesh portion of the constructs 
after 4 weeks post-operatively, establishing firm attachment. However, after 24 weeks, 
gaps were visible surrounding the PVA hydrogels (Fig. 2.8). Encouragingly, no 
pathological changes were observed in the articular cartilage opposing the PVA hydrogel 
implant [191]. 
 
Elisseeff et al. have investigated the chemical attachment of photopolymerizable PEG 
hydrogels to surrounding tissue through tissue-initiated photopolymerization [22]. In this 
method, the proteoglycans in the tissue surrounding a cartilage defect are digested, 
tyrosyl radicals are generated in the collagen by photooxidation of tyrosine residues, and 
a PEG macromer solution is injected into the defect and photopolymerized via tyrosyl 
radical initiation (Fig. 2.9) [22]. In this way, photopolymerizable PEG gels can be formed 
in situ and crosslinked to collagen fibrils in the surrounding tissue, resulting in tight 
integration of the hydrogel to the cartilage.  
 
A similar approach was used in the design of an adhesive bridge between PEG hydrogels 
and surrounding tissue using a bioadhesive based on chondroitin sulphate [193]. The 
polysaccharide was modified with methacrylate groups to bind to photopolymerizable 
PEG hydrogels and with aldehyde groups to react with amines in surrounding tissue via a 
Schiff’s base reaction. Hydrogels encapsulating chondrocytes were attached to cartilage 
explants and implanted subcutaneously in athymic mice for 5 weeks; cells remained 
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viable and the hydrogels remained firmly attached to the cartilage [193]. Mechanical 
evaluation indicated that the hydrogel failed before the interface did. 
 
Tissue adhesives that are clinically in use are based on cyanoacrylates, glutaraldehyde, 
which crosslink to proteins in the surrounding tissue, or fibrin glue, which is induced to 
gel in the presence of thrombin. Cyanoacrylate and glutaraldehyde glues are generally 
cytotoxic [194-196], and fibrin glue has poor bonding strength [24]. However, when 
chondrocytes were combined with the fibrin glue, adhesion to native cartilage after 6 
weeks in vivo was significantly increased, suggesting that tissue engineering approaches 
can be useful mechanisms of integration [197]. 
 
Tissue-engineered cartilage can integrate well with surrounding cartilage without the use 
of any fixatives, and has been shown in animal studies and clinically in matrix-assisted 
ACI [104, 107, 198]. However, conflicting information abounds regarding the optimal 
stage of tissue-engineered cartilage for successful integration upon implantation. 
Mosaicplasty, the transplantation of autologous grafts from less weight-bearing areas into 
a cartilage defect, relies on the integrative properties of mature cartilage [84]. In one 
study, 83% of patients treated showed congruent cartilage surfaces [84]. When 
chondrocytes were pre-cultivated in a type II collagen scaffold for 4 weeks in vitro, they 
repaired cartilage defects in vivo in a canine model better than constructs that had been 
pre-cultivated in vitro for 12 hours, with more defect filling and less fibrous tissue [132]. 
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However, in an in vitro model of engineered cartilage tissue implanted into defects in 
cartilage explants and culture for 4 weeks in rotating bioreactors, immature tissue that 
had been pre-cultivated in vitro in PGA mesh scaffolds for 5 days before implantation 
integrated better with native cartilage, with higher interface failure strength in a push-out 
test, than did mature tissue that had been pre-cultivated for 5 weeks prior to implantation 
[198]. The immature engineered tissue also integrated better than the native cartilage 
explant that was implanted right back into the defect from which it was removed [198]. In 
contrast, in another study using the same model, also with cartilage engineered in PGA 
scaffolds but without the rotating bioreactor, mature engineered cartilage (5 weeks of pre-
cultivation) integrated better with the native tissue than immature engineered cartilage (5 
days of pre-cultivation) [25]. With an additional 20 days of culture, the failure strength 
decreased for mature engineered tissue but increased for immature cartilage tissue [25]. 
 
The strength of integration between engineered tissue and native tissue also depends on 
the tissue engineering matrix. Cartilage that was cultivated in fibrin gels integrated better 
with native tissue than cartilage grown in agarose gels or in PGA scaffolds [25]. 
Adhesion strength was also shown to increase when the surrounding tissue was treated 
with trypsin to remove glycosaminoglycans, which stimulated chondrocytes to proliferate 
[198]. The role of chondrocytes in the engineered tissue and in the surrounding cartilage 
was further elucidated in a sandwich model in which chondrocyte-seeded collagen 
scaffolds were sandwiched between two discs of cartilage, held together by clips, and 
culture in vitro for 40 days [199]. Cartilage tissue formed in the scaffold and integrated 
well with both discs, and chondrocytes had migrated from the scaffold into the cartilage 
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discs. Somewhat less cartilage tissue also formed in non-cell-seeded scaffolds between 
the discs, indicating that chondrocytes in the cartilage discs migrated into the scaffolds, 
which were about 1.5-2mm thick [199]. 
 
These studies show that integration between tissue engineered constructs and the 
surrounding tissue can be accomplished through chemical crosslinking or through 
biological interactions between the tissues. In that case, it is not clear what level of 
cartilage formation is required for successful integration. The combination of 
biomaterials with stimulatory growth factors has been shown to repair cartilage defects 
without any seeded cells and to enhance the formation of cartilage by seeded cells. The 
controlled release of growth factors may therefore play an important role in enhancing 
integration of tissue-engineered cartilage with surrounding tissue. 
 
2.9. Controlled release of growth factors  
 
Many studies have demonstrated the usefulness of the addition of growth factors in 
strategies to repair cartilage tissue. Insulin-like growth factor-1 (IGF-1) is a 7.6kDa 
protein that is pivotal in regulating cell proliferation and differentiation, as well as matrix 
synthesis [200]. The transforming growth factor (TGF) family is involved in 
chondrogenesis of stem cells, chondrocyte proliferation, and matrix synthesis [200]. A 
subfamily of the TGF family are bone morphogenetic proteins (BMPs), which help to 
stimulate proteoglycan and type II collagen synthesis. Basic fibroblast-derived growth 
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factor (bFGF) is found in abundance in developing cartilage and stimulates chondrogenic 
differentiation of mesenchymal stem cells [201]. 
 
These growth factors have also been shown to improve the quality of engineering 
cartilage when added exogenously to chondrocytes encapsulated in hydrogels in vitro 
[202-204]. However, the short half-lives of these growth factors, in addition to rapid 
diffusion or clearance from the defect site, prevent their therapeutic potential [205]. 
Therefore, many have turned to drug delivery systems to provide controlled, sustained 
release of growth factors, eliminating the need for multiple injections.  
 
Production of cartilage extracellular matrix was higher in chondrocyte-seeded chitosan 
scaffolds that released TGFß1 for one week than in scaffolds without TGFß1 [206, 207]. 
Release of IGF-1 from silk scaffolds over 29 days induced chondrogenic differentiation 
of human mesenchymal stem cells when cultured in vitro [208]. Sustained release of 
bFGF over 14 days from gelatin microparticles embedded in gelatin-chondroitin-
hyaluronan scaffolds resulted in increased cartilage formation by seeded chondrocytes 
and enhanced repair of osteochondral defects in rabbits, compared to scaffolds without 
controlled release systems [209].  
 
When collagen sponges impregnated with BMP2 were implanted into cartilage defects in 
rabbits, repair of the defects was better after one year than those treated with collagen 
sponges without BMP2 [210]. The repair tissue that formed in the defects with BMP2 
was also more integrated with the healthy cartilage tissue. However, some BMPs have 
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also been shown to inhibit the proliferation of chondrocytes by causing a reduction in 
type I collagen synthesis, the degeneration of proteoglycan components, and the 
formation of osteophytes, characteristic of osteoarthritic cartilage [200, 211]. 
 
Hydrogels have long been popular as controlled delivery systems for proteins, because 
release profiles can be modulated by changing the hydrogel crosslinking density, which 
changes the free space available for diffusion [4]. The mechanisms of release can also be 
varied by manipulating interactions between encapsulated proteins and the hydrogel 
polymer, such as charge interactions, or by changing the degradation profiles of the 
hydrogels [4, 212]. 
 
In addition, proteins and cells can be easily co-encapsulated in hydrogels. Holland et al. 
employed oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds to deliver IGF-1 over 
4 weeks in cartilage defects in adult rabbits and found that the quality of repair tissue was 
higher than in hydrogels without IGF-1 [169]. The addition of IGF-1 to fibrin 
composites, which allowed release over 21 days, enhanced repair of osteochondral 
defects in horses, although the repair was not as successful as fibrin composites that 
contained chondrocytes without additional growth factors, indicating that a combined 
approach involving tissue engineering and controlled release may be more effective than 
controlled release alone [213]. When IGF-1 was co-encapsulated with chondrocytes, the 
repair of chondral defects in horses was greater than IGF-1 or chondrocytes alone [214]. 
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One of the most common drug delivery systems for sustained release of proteins is 
polymeric microparticles, especially those composed of poly(lactic acid), poly(glycolic 
acid), and poly(lactic-co-glycolic) acid (PLGA) [215].  The release of entrapped protein 
is controlled by the degradation of the polymer, because diffusion is prevented by the low 
solubility of proteins in hydrophobic polymers [216]. An initial burst of the drug typically 
occurs because of the erosion of the surfaces of the microparticles and the subsequent 
release of drug located near the surfaces. After the initial burst, the drug typically releases 
linearly, diffusing through pores created in the linearly eroding matrix. PLGA degrades 
by ester hydrolysis of the backbone [216, 217]. Porous scaffolds have been prepared by 
fusing PLGA microparticles together in dichloromethane vapor and allow the controlled 
release of IGF-1 and TGFβ-1 continuously or sequentially for up to 70 days in active 
form [218]. 
 
The encapsulation of PLGA microparticles in scaffolds and hydrogels is a useful tool for 
controlling the release of growth factors from tissue engineering scaffolds. The molecular 
weight, composition, and end groups of PLGA, the porous structure of the resultant 
microparticles, and the drug loading can be varied to modify the release kinetics [219-
222]. Embedding microparticles within scaffolds or hydrogels tempers release profiles 
[219, 220, 223], allows spatial control over delivery [224], and can lead to greater 
stability and bioactivity of the encapsulated protein [219].  
 
When PLGA microparticles containing IGF1 and TGFß1 were co-encapsulated with 
chondrocytes in PEG hydrogels the growth factor release was controlled over 15 days 
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and resulted in increased cartilage matrix production in vitro [222]. However, when OPF 
hydrogels loaded with IGF-1, TGFß-1, or a combination of the two, were implanted into 
osteochondral defects in rabbits, IGF-1-releasing hydrogels were the most effective in 
improving cartilage repair, with little to no improvements in hydrogels releasing TGFß-1 
only or a combination of TGFß-1 or IGF-1 [169]. These results were in stark contrast to 
previous studies in vitro, which indicated that TGFß-1 alone or a synergistic combination 
of TGFß-1 and IGF-1 improved cartilage tissue generation in hydrogels [168]. These 
results suggest that delivery of IGF-1 is a more promising strategy for enhancing 
cartilage repair, but caution should be exercised when translating in vitro results to in 
vivo repair. Another complicating factor will be the diminished response of arthritic and 
aged chondrocytes to IGF-1, which will complicate dosage calculations and further 
increase the disparity between in vitro results, animal models and repair in humans [225]. 
 
The use of controlled release of growth factors in combination with carefully designed 
biomaterials may result in improved cartilage tissue engineering. Furthermore, the 
chemoattractive effects of these growth factors may enhance integration with surrounding 
tissue by further stimulating chondrocytes to migrate towards the scaffolds [199, 226, 
227]. 
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Figure 2.1. Anatomy of the knee joint (www.healthbase.com). 
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Figure 2.2. Schematic of the zonal structure of articular cartilage, showing depth-
dependent variations in (A) chondrocyte morphology and (B) collagen fibril alignment 
(ajs.sagepub.com). 
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Figure 2.3. Schematic of method of subchondral drilling to repair a cartilage defect 
(www.jointpreservationcenter.com). 
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Figure 2.4. Schematic of classical autologous chondrocyte implantation (medscape.com). 
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(a)       (b) 
  
 
 
Figure 2.5. (a) Chemical structure of chitosan, and (b) chemical structure of chondroitin-
sulfate, where R-groups are sulfate groups. 
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Figure 2.6. Chemical structure of methacrylated PEG with and without hydrolytically 
labile lactic acid (from Bryant and Anseth 2003).  
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Figure 2.7. Chemical structure of PVA and PVP (from Thomas et al. 2003). 
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Figure 2.8. Gaps surrounding PVA hydrogel-titanium fiber mesh composite, implanted 
into femoral condyles in dogs, after 24 weeks (from Chang et al. 1998). 
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Figure 2.9. Tyrosyl initiation of photopolymerization of hydrogels crosslinked to collagen 
in surrounding tissue (from Wang et al. 2004). 
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Chapter 3: Research Goals 
 
This work focuses on the combination of the integrative and cell adhesive properties of 
PLGA scaffolds with the mechanical advantages of PVA hydrogels.  First, PVA 
hydrogels were made superporous, so that chondrocytes could be seeded throughout the 
porous network and induced to develop healthy cartilage tissue.  Since PVA hydrogels 
are nondegradable, the result would be a hybrid hydrogel-cartilage construct that may 
integrate well with surrounding tissue.  Moreover, the nondegradable nature of the PVA 
hydrogel would prevent the mechanical properties from diminishing over time, as is the 
case with degradable scaffolds.  
 
Several methods of incorporation of PLGA microparticles into the PVA hydrogels were 
investigated. Processing parameters such as the molecular weight and amount of PLGA, 
the type and volume of organic solvent used in the PLGA solution, the initial freezing 
temperature and the stirring speed, were analyzed for their effects on hydrogel porosity, 
pore size, and swelling behavior. The hydrogels were then mechanically tested in three 
different tests for comparison to cartilage.  The hydrogels were then evaluated as 
cartilage replacement materials in terms of their dynamic structure, mechanical 
properties, and swelling properties, over the course of swelling in model osmotically-
conditioned systems. PBS solutions were osmotically conditioned through the addition of 
poly(ethylene glycol) (PEG), and validated by comparing the swelling behavior of 
hydrogels in these solutions to that in cartilage explants.  The hydrogels were then 
characterized for their ability to support cartilage formation by encapsulated cells. 
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Finally, the hydrogels were evaluated in terms of their ability to release insulin-like 
growth factor-1 (IGF-1) at a controlled and sustained rate. The effects on cartilage 
formation and integration with surrounding tissue were examined by wrapping the 
hydrogels in PGA fibers that were seeded with chondrocytes. This system was evaluated 
in vivo by subcutaneous implantation into a nude mouse model. 
 
The specific aims of this work are to: 
1. Design superporous, semi-degradable hydrogels based on PVA and PLGA. 
2.  Characterize the mechanical properties of superporous hydrogels. 
3. Characterize the swelling behavior of the hydrogels in model systems. 
4. Evaluate the effects of hydrogel properties on support of chondrogenesis. 
5. Develop the hydrogels as controlled release systems and evaluate their efficacy as 
cartilage tissue engineering scaffolds in vivo. 
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Chapter 4: Design of superporous, semi-degradable hydrogels based on PVA 
4.1. Introduction 
 
The preparation of PVA hydrogels requires physical crosslinking through cycles of 
freezing and thawing. This is a simple method to prepare relatively stiff hydrogels, but 
cells cannot be incorporated into the hydrogels until after processing. In order to form a 
hybrid cartilage-hydrogel construct, the hydrogels must be rendered porous so that cells 
can be seeded. 
 
Several techniques have been employed to introduce macroporosity to hydrogels, such as 
porogen extraction, phase separation, foaming, and rapid prototyping or solid free form 
fabrication [228]. Control of porosity or type of monomer is limited in all of these 
methods [229]. 
 
The addition of PLGA microparticles was hypothesized to add some initial degree of 
porosity to the hydrogels, which would substantially increase as the microparticles 
degrade within the nondegradable hydrogels, leaving behind pores. In addition, 
microparticles are a common drug delivery system, and would allow the controlled 
release of stimulatory growth factors. Moreover, scaffolds composed of PLGA have been 
shown to support cartilage formation by seeded chondrocytes, and may impart this 
characteristic to the PVA hydrogels. 
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In this work, the incorporation of PLGA microparticles into PVA hydrogels was 
investigated using several methods. First, microparticles were prepared using 
conventional techniques based on the water-oil-water double emulsion, solvent-
evaporation technique and subsequently embedded into hydrogels during the physical 
crosslinking process. The combination of these processes in a novel approach was 
investigated by preparing microparticles using the hydrogel solution as the external 
aqueous phase. The effects of processing parameters were evaluated with the goal of 
controlling the composition, structure and swelling properties of the hydrogels. Such 
control will allow detailed analysis of the effects of various design parameters, such as 
porosity, average pore size, and swelling behavior, on cartilage tissue engineering. 
 
4.2. Materials and Methods 
4.2.1. Materials 
 
PVA (99% hydrolyzed, molecular weight 96,000), poly(vinyl pyrrolidone) (PVP) of 
molecular weight 40,000, dichloromethane, ethyl acetate, and acetone were purchased 
from Sigma-Aldrich (St. Louis, MO). PLGA 50:50 with a molecular weight of 65,000 
(DL2A or DL4A) was purchased from SurModics Pharmaceuticals (Birmingham, AL). 
PVA (88% hydrolyzed, molecular weight 25,000) was purchased from Polysciences, Inc. 
(Warrington, PA). Poly(ethylene glycol) (PEG) 20,000 was purchased from Crescent 
Chemical Company, Inc. (Islandia, NY).  
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4.2.2. Suspension Method of pre-fabrication of microparticles and incorporation into 
hydrogels  
 
A schematic of the Suspension Method of hydrogel fabrication is shown in Figure 4.1. 
Microparticles of PLGA were prepared by a modified double emulsion, solvent-
evaporation technique. A primary emulsion was formed by adding 12.5vol% PBS to a 
3wt% solution of PLGA in dichloromethane and acetone (2:1) and stirring at 400 rpm for 
30 minutes. This emulsion was added to 10x volume of 2wt% PVA (88% hydrolyzed, 
molecular weight 25,000) in water, and stirred at 400 rpm overnight. The microparticles 
were then collected by centrifugation and washed twice with water.  
 
Hydrogel solutions of 10wt% PVA and PVP in a ratio of 99:1 in deionized water were 
prepared by autoclaving at 121°C for one hour. Microparticle suspensions (15wt%) were 
added to the hydrogel solution to final concentrations of 0, 2, and 4wt%, and stirred at 
300 rpm for 10 minutes. The mixtures were then poured into 24-well polystyrene tissue 
culture trays and subjected to six cycles of freezing at -20°C for 21 hours and thawing at 
room temperature for 3 hours.  
 
4.2.3. Direct Incorporation Method of microparticle and hydrogel fabrication 
 
A schematic of the Direct Incorporation Method of hydrogel fabrication is shown in 
Figure 4.2. A novel technique based on a double emulsion was also explored to directly 
incorporate PLGA microparticles into PVA hydrogels. The primary emulsion, formed by 
adding a small amount of phosphate-buffered saline (PBS) to a solution of 50:50 PLGA 
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in DCM or ethyl acetate (EA) was sonicated for 5 minutes and then added dropwise to a 
solution of 10% PVA-PVP (99:1 PVA:PVP) in water. This emulsion was stirred for ten 
minutes, poured into tubes, and frozen at -20°C or in an acetone/dry ice bath at -80°C, 
before being exposed to six cycles of freezing at -20°C for 21 hours and thawing at room 
temperature for 3 hours. The hydrogels were then sliced into cylinders that were 
approximately 15mm in diameter and 4mm in height, and either washed in PBS to 
remove organic solvent, or dehydrated through an ethanol series and dried by critical 
point drying.  
 
Several parameters were varied to analyze the effects on the resultant hydrogel 
properties. First, the effects of organic solvent were determined for DCM and EA at two 
different levels of PLGA content. Then, the relative PLGA content was varied from 20 to 
60wt% of the dried hydrogels while holding the volume of DCM used in the organic 
phase at 35vol% of the emulsion. Hydrogels were also prepared without PLGA but with 
10vol% DCM, which was the highest volume of DCM that could be used in preparation 
of control hydrogels without PLGA with consistent results. Next, the PLGA content was 
held constant at 60wt% and the volume of DCM was varied from 25 to 55vol%. Finally, 
hydrogels were prepared using 30 and 60wt% PLGA with inherent viscosities of 2 and 
4dl/g. 
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4.2.4. Characterization of hydrogel microstructure 
 
Initial characterization of the hydrogels was performed using environmental scanning 
electron microscopy (ESEM) (Model: FEI/Phillips XL30), so that they could be imaged 
in the fully hydrated state. These hydrogels were washed following physical crosslinking, 
and not dried. The average diameters of microparticles (n=1000) and hydrogel porosity 
were determined using the public domain ImageJ program developed at the US National 
Institutes of Health [230]. For each ESEM image, the areas of the pores were divided by 
the total sample areas to obtain percent porosity (n=2 hydrogels, 12 images/hydrogel). 
This large number of images was analyzed in an effort to fully assess the hydrogel 
microstructure. 
 
For hydrogels prepared using DCM while varying the parameters of PLGA type and 
content and volume of DCM, hydrogels from separate batches were analyzed to assess 
batch-to-batch consistency. These hydrogels were dried by critical point drying. This 
allowed the samples to be analyzed using micro-computed tomography (µCT) (Skyscan 
1172, Kontich, Belgium) (n=2 hydrogels per batch, 3 batches). The resolution was 2.9µm 
and the x-ray source was 61kV. The data were reconstructed using cone-beam 
reconstruction software (Nrecon, Skyscan). Three hundred images per sample were 
segmented into binary images using greyscale values (15-30) that were validated against 
ESEM images of the dry samples. These images were used to build 3-D virtual models 
and to determine porosity based on volume of a 0.75mm x 0.75mm x 0.9mm 
representative portion (CTAnalyzer, Skyscan). Average pore size was determined by 
measuring the diameters of all of the pores in 5 binarized images per sample (n=2 
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hydrogels per batch, 3 batches). The microstructure of the rehydrated hydrogels was 
analyzed by viewing cross-sections of hydrogels that had been immersed for 3 days in 
PBS at 37°C (n=1 hydrogel per batch, 3 batches, 5 images per hydrogel) using wet-mode 
ESEM. 
 
4.2.6. Statistical Analysis 
 
All data points are represented as the mean ± one standard deviation. Statistical 
significance was determined by one way analysis of variance (ANOVA) with post-hoc 
analysis by Tukey’s test. P-values less than 0.05 were considered statistically significant. 
 
4.3. Results & Discussion 
4.3.1 Analysis of Suspension Method of hydrogel fabrication 
 
The freezing and thawing method of PVA cross-linking is attributed to the crystallization 
of highly concentrated regions of aqueous PVA, which form as water freezes. Crystallites 
form in the PVA phase and hydrogen bonds form between chains, resulting in a three-
dimensional hydrogel network that is insoluble in water [176-178]. Intrachain physical 
cross-links are formed between hydroxyl groups of the PVA and interchain cross-links 
form between the hydroxyl groups of PVA and the carbonyl groups of PVP, and the 
hydrogels have increasing mechanical strength with repeated freezing and thawing [16, 
179]. 
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PLGA microparticles, prepared by a double emulsion, solvent-evaporation technique, 
were smooth with an average diameter of 30±17um (Fig. 4.3). Microparticles were 
physically incorporated into the hydrogel solution in amounts of 0, 20, and 40wt% by 
stirring, and the mixtures were exposed to six cycles of freezing and thawing, causing 
physical cross-linking and the formation of the hydrogel around the microparticle-water 
suspension. The result was porous, non-degradable hydrogels based on PVA-PVP with 
an incorporated phase of degradable PLGA microparticles (Fig. 4.4). Hydrogels without 
microparticles were not porous, but the addition of microparticles resulted in porosities of 
29.0±11.8 and 52.1±7.67% for hydrogels prepared with 20 and 40wt% microparticles, 
respectively. The introduction of porosity to the hydrogels is attributed to incomplete 
solution of the water in the suspension with the hydrogel solution, as well as hydrophobic 
interactions between the microparticles and the water. 
 
Although the Suspension Method allows precise control over the microparticle 
morphology, high levels of initial porosity could not be achieved. To incorporate 
microparticles in a way that creates superporous hydrogels, the Direct Incorporation 
method was developed. 
 
4.3.2. Analysis of Direct Incorporation Method of hydrogel fabrication 
 
Porous PVA–PVP hydrogels were synthesized through introduction of various organic 
solvents during the mixing and casting process. PLGA microparticles were directly 
incorporated into hydrogels by using the hydrogel solution as the external aqueous phase 
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in the double emulsion method of microparticle preparation (Fig. 4.5). The introduction 
of porosity occurs because of the liquid–liquid phase separation between the organic 
PLGA solution and the aqueous PVA–PVP solution. The pores, therefore, represent 
locations where organic solvent was present prior to the physical cross-linking. In 
addition, degradable PLGA microparticles form through the double emulsion technique. 
Under physiological conditions, these microparticles should degrade hydrolytically and 
leave pores in the non-degradable PVA–PVP matrix, increasing the hydrogels’ porosity 
over time. This double emulsion method of hydrogel fabrication is a novel way to create 
very porous scaffolds with high compressive moduli, which is extremely important for 
this application, since cartilage withstands enormous stresses. Numerous studies have 
shown the importance of sufficient porosity for tissue integration and the need to 
maintain mechanical integrity for orthopedic applications [2, 228, 231-234], especially 
for cartilage tissue formation [234].  
 
Hydrogels were first prepared by according to the double emulsion method, and then 
washed in PBS to remove any residual organic solvent. In a different method, to allow 
greater control over processing conditions, the hydrogels were flash-frozen at -80°C in an 
acetone/dry ice bath, so that higher volumes of the organic phase could be incorporated 
without macroscopic phase separation. These hydrogels were washed and then dried by 
critical point drying, which did not change their size but allowed detailed analysis using 
micro-computed tomography (µCT). 
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4.3.2.1. Method 1: Freezing at -20°C and washing with PBS  
 
Because DCM and EA are non-solvents for the hydrogels, they can be exchanged with 
water by submerging the hydrogels in water. Hydrogels were imaged in their hydrated 
state using ESEM. The representative images for hydrogels synthesized with DCM or EA 
are shown in Fig. 4.6. All samples had a well-defined pore network. Generally, the pores 
had a circular structure but varied greatly in diameter within each hydrogel type. Round 
microparticles, embedded in the matrix, were around 10–50µm in diameter, and were 
most clearly visible in the higher wt% PLGA hydrogels, 20wt%–10vol% and 20wt%–
25vol%, and were less apparent in the low PLGA wt% hydrogels. A rough surface 
morphology was seen in the image of the control hydrogel, prepared without solvent, but 
no discernible pore network were detected in the control images.  
 
Because samples can be imaged in a wet environment using ESEM, the structure of the 
hydrogels is not changed through drying. ImageJ, a publicly available image processing 
program, was chosen as the most appropriate method to determine the porosity from 
ESEM images. However, some challenges were encountered with this method because of 
its subjectivity. The program requires the user to manually select the areas to be 
designated as pores by image contrast comparison, which is qualitative in nature. In spite 
of this limitation, ImageJ is a good method for measuring porosity of the hydrogels in the 
hydrated state, a key feature lacking in traditional porosity measuring techniques, as long 
as large sample sizes and consistency in selecting pore areas are employed.  
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Fifteen images were taken of each sample, from cross-sections from the top, middle and 
bottom of the hydrogel. To ensure that the images captured were accurate representations 
of the general pore structure, as opposed to intentionally or unintentionally choosing the 
most interesting locations, the images were taken at predetermined coordinates at various 
depths in the samples. By examining the cross-sections at varying depths in the 
hydrogels, we determined that the pore distribution was fairly uniform throughout the 
depth of each sample (Fig. 4.7). Due to technical limitations regarding the field of view 
available using the ESEM, it was not possible to capture an image at a low enough 
magnification to show the distribution of pores throughout each sample. However, 
images were taken at many locations across cross-sections of the hydrogels, and the 
values of porosity generated from each position were used to calculate the average 
percent porosity for each sample. Thus, the standard deviation of the percent porosity 
(Table 4.1) are an indication of homogeneity of pore distribution. Increasing the solvent 
from 10 to 25vol% caused an increase in porosity for hydrogels made with both DCM 
and EA, with all increases statistically significant (p<0.05) except for the hydrogels made 
with 20wt% PLGA and both volume percentages of EA. Samples made with 20wt% 
PLGA and 10vol% EA had a greater degree of porosity than the hydrogels made with 
DCM and the same composition (p<0.05). All samples showed a higher porosity than the 
control hydrogel, which had 0% porosity (p<0.05).  
 
Porosity increased with increasing content of organic solvent, but was unaffected by 
PLGA content, except for the hydrogels made with 10vol% EA (Table 4.1). The increase 
in porosity is be a result of the separation of the organic phase from the aqueous hydrogel 
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solution, so that crystallization and cross-linking occur around the droplets of organic 
solvent. For this reason, increasing the volume of organic solvent increases the porosity 
of the hydrogel.  
 
Increasing the PLGA content for the hydrogels made with 10vol% EA caused an increase 
in porosity, the only statistically significant result of increasing the PLGA content. The 
change in the degree of interactions between the scaffold and the PLGA phase may be a 
result of the large change in miscibility with water from DCM to EA. Further studies 
involving hydrogels prepared with solvents of varying miscibilities, such as acetone and 
dimethyl sulfoxide, might elucidate the source of porosity. 
 
The highest volume of organic solvent that could be employed in the preparation of these 
hydrogels was 25vol%, and greater volumes resulted in macroscopic phase separation 
and unpredictable results. However, when the hydrogels were first flash-frozen in an 
acetone/dry ice bath at -80ºC, higher volumes could be added with consistent results. 
Further experiments were conducted using this method, resulting in analysis of a wider 
range of processing parameters. 
 
Although values of porosity calculated from ESEM images using ImageJ are deemed to 
be accurate for the images analyzed, only the surfaces of the hydrogels can be imaged, 
prohibiting a detailed analysis of the pore structure throughout the hydrogel. Critical 
point drying is a specimen drying technique that involves exchanging the solvent of the 
sample to liquid carbon dioxide, and then raising the temperature and pressure above a 
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critical point so that the carbon dioxide instantly evaporates, leaving behind the sample 
theoretically without a change in structure. For hydrogels, critical point drying actually 
increases the porosity slightly because as the solvent is removed (Fig. 4.8). By drying the 
hydrogels through critical point drying, µCT can be used to analyze the samples, 
allowing computer automated image contrast analysis to obtain values of porosity based 
on the entire sample, not just a single cross-section. 
 
4.3.2.2. Method 2: Freezing at -80ºC and critical drying  
 
The effects of varying the processing parameters of PLGA content, DCM content, and 
PLGA inherent viscosity were examined with respect to their control over hydrogel 
properties and batch-to-batch consistency. Hydrogels containing 20, 30, 40, and 60wt% 
PLGA microparticles, expressed as a percentage of the dry hydrogels, were prepared by 
blending aqueous PVA-PVP solutions with organic solutions of PLGA in 35vol% DCM. 
Porous hydrogels without PLGA were prepared using 10vol% DCM, because higher 
volumes resulted in macroscopic phase separation during the first freeze-thaw cycle. The 
organic solvent was removed from the final hydrogels during washes and critical point 
drying. The structures of the hydrogels were analyzed using samples taken from separate 
batches in order to assess batch-to-batch consistency.  
 
These hydrogels had much higher levels of porosity and interconnectivity than hydrogels 
prepared with lower volumes of organic solvent and that were not dried, described above. 
Average pore sizes ranged from 50 to 100µm (Fig. 4.9, 4.10). Upon increasing PLGA 
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content, there were decreases in porosity, average pore size, and water content after 3 
days of rehydration in PBS (Fig. 4.10, 4.11, 4.12). These trends are not surprising since 
increasing the PLGA content resulted in an increase in total polymer content during 
hydrogel fabrication. Increases in PLGA content would also cause decreases in swelling 
since PLGA is much more hydrophobic than PVA. 
 
In general, increasing the volume of organic solvent used to prepared hydrogels 
containing 60wt% PLGA resulted in increases in total porosity, average pore size, and 
water content after 3 days of swelling in PBS (Fig. 4.13-4.16). Higher porosity and larger 
pores naturally resulted in higher swelling. To determine if the increases in porosity were 
due to an increase in solvent or a decrease in the viscosity of the organic phase, hydrogels 
were also prepared with PLGA of a lower inherent viscosity at 30 and 60wt% PLGA in 
35vol% DCM. A decrease in the inherent viscosity of the PLGA caused decreases in 
porosity and pore size for hydrogels prepared with both levels of PLGA (p<0.05) (Fig. 
4.17-4.20).  
 
The Direct Incorporation method of microparticle and hydrogel fabrication resulted in 
superporous hydrogels, with much greater control over the initial structure than the 
Suspension Method. Changes in initial processing parameters, such as type and volume 
of organic solvent, initial freezing temperature, drying method, and PLGA content and 
inherent viscosity, allowed a high level of control over the structure, composition, and 
swelling properties. The incorporation of PLGA microparticles into PVA hydrogels in 
ways that allow control over the structure will allow detailed analysis of the effects of 
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various hydrogel properties on mechanical and swelling behavior and on support of 
cartilage formation. 
 
4.4. Conclusions 
 
In this study, the simple blending of a PLGA solution throughout the hydrogel solution 
prior to physical crosslinking resulted in an interspersed phase of PLGA microparticles in 
a highly porous network. The porosity is a result of crosslinking of the hydrogel solution 
around the organic phase. The degradability, porosity, average pore size, and swelling 
properties of the hydrogels can be controlled by varying initial processing parameters and 
were consistent across batches. It is important to note that the hydrogels are semi-
degradable, and once the PLGA degrades, they become fully nondegradable. Their 
mechanical properties would therefore not decrease with time, as is the case with fully 
degradable scaffolds. The purpose of the PLGA phase is to simultaneously add porosity 
and cell adhesiveness to the hydrogels, so that the hydrogels can be seeded with 
chondrocytes and support cartilage formation, which is not possible for unmodified PVA 
hydrogels. 
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Table 4.1. Porosity, determined using ESEM images and the program ImageJ, of 
hydrogels prepared using the Direct Incorporation method. 
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Figure 4.1. Schematic of Suspension Method of microparticle and hydrogel fabrication. 
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Figure 4.2. Schematic of Direct Incorporation method of microparticle and hydrogel 
fabrication. 
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Figure 4.3. (a) ESEM image of microparticles and (b) microparticle size distribution. 
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Figure 4.4. Representative ESEM images of hydrogels prepared using the Suspension 
Method with 20wt% PLGA microparticles. 
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Figure 4.5. Cross-section of representative hydrogel showing PLGA microparticles 
(arrows). 
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Figure 4.6. Representative ESEM images of each sample type showing pore size 
distribution and PLGA incorporation. 
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Figure 4.7. ESEM images of three cross-sections of the 25wt% PLGA/ 10vol% DCM 
hydrogel, showing sample uniformity. 
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Figure 4.8. Representative ESEM images showing cross-sections of hydrogels before (a, 
c) and after (b, d) critical point drying and subsequent rehydration for 8 hours. Hydrogels 
were prepared with (a,b) 20wt% PLGA/ 10vol% DCM and (c,d) 20wt% PLGA/ 25vol% 
DCM. 
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Figure 4.9. Representative ESEM images of hydrogels at 0, 20, 30, 40, 60wt% PLGA, 
prepared with 35vol% DCM (except 0wt%, which were prepared with 10vol% DCM). 
Scale bars are 200µm. 
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Figure 4.10. Average pore size, determined using µCT, of hydrogels prepared with 
increasing PLGA contents. (n=6, *p<0.05) 
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Figure 4.11. Porosity, determined using µCT, of hydrogels prepared with increasing 
PLGA contents. (n=6, *p<0.05) 
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Figure 4.12. Water content of hydrogels prepared with increasing PLGA contents after 
rehydrating for 3 days in PBS at 37°C. (n=9, *p<0.05) 
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Figure 4.13. Representative ESEM images of cross-sections of hydrogels prepared with 
increasing DCM content. Scale bars are 200µm. 
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Figure 4.14. Porosity, determined using µCT, of hydrogels prepared with increasing 
DCM contents. (n=6, *p<0.05) 
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Figure 4.15. Average pore size, determined using µCT, of hydrogels prepared with 
increasing DCM contents. (n=6, *p<0.05) 
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Figure 4.16. Water content of hydrogels prepared with increasing DCM contents after 
rehydrating for 3 days in PBS at 37°C. (n=9, *p<0.05) 
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Figure 4.17. Representative ESEM images of cross-sections of hydrogels prepared with 
PLGA of inherent viscosities of 2 and 4dl/g at 30 and 60wt% PLGA. Scale bars are 
200µm. 
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Figure 4.18. Porosity, determined using µCT, of hydrogels prepared with PLGA of 
inherent viscosities of 2 and 4dl/g at 30 and 60wt% PLGA (n=6, *p<0.05). 
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Figure 4.19. Pore size, determined using µCT, of hydrogels prepared with PLGA of 
inherent viscosities of 2 and 4dl/g at 30 and 60wt% PLGA (n=6, *p<0.05). 
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Figure 4.20. Water content of hydrogels prepared with PLGA of inherent viscosities of 2 
and 4dl/g at 30 and 60wt% PLGA after rehydrating for 3 days in PBS at 37°C. (n=9, 
*p<0.05) 
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Chapter 5: Characterization of the mechanical properties of superporous hydrogels 
5.1. Introduction 
 
Cartilage withstands some of the highest stresses in the body, so a biomaterial to replace 
damaged cartilage must also have the capacity to withstand high loads. Because the 
mechanical properties of cartilage rely on swelling pressure generated by proteoglycans 
and interstitial fluid flow [38, 65], degradable scaffolds that are not swollen in water do 
not exhibit similar mechanical behavior to healthy cartilage. Hydrogels, on the other 
hand, do exhibit fluid flow that is similar to cartilage, but are typically not stiff enough to 
support loads found in the knee [9]. Tissue engineered cartilage, grown in vitro or in vivo, 
does not have the requisite mechanical properties either, and is crushed under 
physiological loads [235]. The mechanical properties of an implant must be mechanically 
biomimetic; a biomaterial that is too soft would be unable to support physiological loads, 
but one that is too stiff may result in harmful stress-shielding from the surrounding tissue. 
 
Several researchers have shown that there exists an inverse relationship between porosity 
and mechanical properties [231]. The introduction of porosity to these hydrogels must, 
therefore, result in a reduction in mechanical properties. The focus of this work is to 
characterize the mechanical behavior of the hydrogels in comparison to cartilage, and to 
determine the important hydrogel properties that affect mechanical properties. An 
understanding of the relationship between hydrogel structure and resultant mechanical 
properties will allow the properties to be tailored to match healthy cartilage. 
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Hydrogels, both swollen and rehydrated after drying, were prepared using the Direct 
Incorporation method. The mechanical properties of the hydrogels were measured in 
uniaxial, unconfined, static compression and compared to uniaxial, unconfined, stress-
relaxation tests, a common method of testing cartilage in the field. The hydrogels were 
also tested in confined creep, allowing both direct comparison to cartilage and analysis of 
the effects of hydrogel parameters on fluid flow properties. 
 
5.2. Methods 
5.2.1. Uniaxial, unconfined compression 
 
Hydrogels (n=6) were sliced to ensure flat parallel surfaces and a thickness of 5-6mm. 
The behavior of the hydrogels in unconfined, uniaxial compression was measured using 
an Instron 50 N load cell, model 4442 (Norwood, MA), and the samples were tested in a 
bath of PBS at 37°C. The samples were pre-loaded to a strain of 10%, and the samples 
were compressed at a rate of 100% strain/minute to 6% strain, for a total strain of 16%. 
The slope of the stress-strain curve was linear, and was defined as the elastic modulus, E. 
 
5.2.2. Unconfined stress-relaxation behavior 
 
Hydrogels (n=4) were also tested in unconfined stress relaxation according to the 
methods of Korhonen et al. [58], allowing comparison to values reported in the literature. 
Hydrogels, sliced flat to ensure parallel surfaces, were tested in a bath of PBS. Hydrogels 
were compressed at a rate of 1µm/sec to 5% strain and held at that strain for one hour 
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before compressing further an additional 5% strain. These steps of stress-relaxation for 
one hour were continued for four cycles, and the values of equilibrium stress were taken 
after one hour of relaxation and plotted against their corresponding strain values, which 
were multiples of 5%. The slope of this curve was linear and is defined as Young’s 
modulus. 
 
5.2.3. Confined creep behavior 
 
Hydrogels were also tested in confined creep behavior for direct comparison to mature 
cartilage. Hydrogels (n=6) were cored using a 5mm diameter biopsy punch and sliced on 
a freezing stage microtome to ensure flat parallel surfaces and a thickness of 2-3mm. 
Mechanical testing was performed on a custom-made test apparatus, the Compression 
Computer Automated Soft Tissue Test System (Hospital for Special Surgery, New York, 
NY). Samples were confined in a 5mm diameter stainless steel well, immersed in 
phosphate buffered saline and loaded via a porous 5mm diameter brass filter. Samples 
were subjected to a creep test as follows: samples were rapidly loaded with at a rate of 
150µm/s up to a load of 50g and allowed to creep for one hour. After testing some 
samples for three hours, it was determined that one hour was sufficient for the hydrogels 
to reach equilibrium. The indenter displacement was recorded throughout testing.  
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5.2.4. Statistical analysis 
 
One way analysis of variance (ANOVA) tests were conducted at a 95% confidence 
interval. Tukey’s test at 5% error rate was performed to compare multiple groups 
simultaneously when differences were found through ANOVA. In all figures, error bars 
represent ± one standard deviation, and statistical significance is defined as p<0.05. 
 
5.3. Results & Discussion 
5.3.1. Uniaxial, unconfined compression 
 
Unconfined compression provides a means to evaluate the elastic modulus of a material. 
Hydrogels prepared using the Direct Incorporation method and washed to remove the 
organic solvent, without drying, behaved elastically when compressed to 16% strain, with 
linear stress-strain curves, in agreement with other studies of PVA hydrogels [9]. 
Representative stress–strain curves for the hydrogels tested in unconfined compression to 
6% strain after an initial pre-strain of 10% are shown in Fig. 5.1. The six samples shown 
in Fig. 5.1 are for the hydrogels made with 10wt% PLGA and 10vol% DCM. Though the 
porous hydrogels behaved similarly to the control hydrogel, there were some differences 
in elastic modulus. The values of compressive modulus are shown in Table 5.1. Samples 
containing 10 or 20wt% PLGA and 10 or 25vol% solvent were compared with the control 
hydrogel containing no PLGA or solvent. For hydrogels prepared with both DCM and 
EA, increasing the solvent concentration at constant PLGA concentration caused a 
decrease in the compressive modulus although this decrease was only statistically 
significant for the 20wt% PLGA DCM hydrogels (p<0.05). Increasing the PLGA 
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concentration for constant solvent concentration resulted in no significant change in 
modulus. All sample had moduli less than the control samples’ value although the 
decrease was only significant for the 25vol% DCM hydrogels (p<0.05). The effect of 
different organic solvents used in hydrogel fabrication on modulus was studied by 
comparing hydrogels with the same PLGA and solvent concentrations but different 
solvent type. This effect was not significant for the conditions investigated although a 
greater differentiation between the two solvent types was observed at higher solvent 
concentrations.  
 
The unconfined compression tests provide a measure of the ability of the material to 
withstand compressive forces without allowing time for fluid flow to equilibrate. The 
increase in porosity shown with increasing solvent concentration correlates to decreases 
in compressive modulus (Table 5.1, Fig. 5.2). The introduction of EA has less of an 
impact on the modulus than DCM does because it has a greater solubility in water than 
DCM, and so interferes less with cross-linking.  
 
The relationship between porosity and elastic modulus may be explained by the increased 
porosity allowing for greater displacement of interstitial fluid from within the hydrogel 
pores, resulting in greater strain at lower stresses, or a lower modulus. Since the water 
within the macropores behaves as an incompressible fluid resisting compression within 
the hydrogel, the modulus would be reduced when less water is present for a hydrogel in 
its non-equilibrium state. The reduction in compressive modulus with increased porosity 
may also be due to a reduction in the solid content of the hydrogels. The strong linear 
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relationship between stress and strain over these strain values (0–16%), similar to native 
articular cartilage [61], shows that the values represent the elastic nature of the hydrogel 
with interstitial fluid. 
 
A common method for measuring the Young’s modulus of articular cartilage is 
equilibrium stress-relaxation, which assumes that there is no interstitial fluid flow at 
equilibrium [58, 59]. Testing biomaterials using this method thus allows comparison to 
values reported for cartilage in a wide range of conditions. The slope of the curve of 
equilibrium stress vs. strain is linear and is defined as Young’s modulus (Fig. 5.3). The 
Young’s moduli of hydrogels prepared using the Suspension Method also varied 
inversely with porosity (Fig. 5.4), confirming the relationship between modulus and 
porosity for hydrogels prepared using the Direct Incorporation method (Figure 5.2). 
Values for Young’s modulus of the control hydrogel, without porosity, determined in 
equilibrium stress-relaxation, were not statistically different from values of compressive 
modulus determined in static compression (Fig 5.5). This approximate comparison 
suggests that values determined in simple compression can be used to estimate Young’s 
modulus, a useful tool for comparison to values reported for cartilage in the literature. 
The Young’s modulus of articular cartilage was found to range from 0.1–0.8 MPa [58, 
59, 236].  
 
 However, it is important to note that the mechanical behavior of articular cartilage is 
complex, and no single measure of mechanical property should be used to definitively 
describe cartilage or biomaterials to replace cartilage. Nonetheless, quick tests such as 
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simple compression are useful for preliminary analysis of biomaterials and determining 
the effects of various parameters.  
 
Confined creep experiments were performed to describe the mechanical and fluid flow 
behavior of the hydrogels and to directly compare the hydrogels to mature articular 
cartilage. The aggregate modulus, HA, and the permeability, k, for each sample were 
determined from the biphasic theory through two parameter nonlinear regression fits 
based on the following equation [61].  
 
     (5.1) 
 
where u is the creep displacement, f0 is a stress parameter and αo0 is the solid content. 
The data and fit for a representative sample and for cartilage are shown in Fig. 5.6. In 
order to further describe the creep behavior, an exponential decay function was fit to the 
strain vs. time curve, shown below.  
 
       (5.2) 
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Here, ε0 is the initial strain that the sample was compressed to before beginning creep, εc 
is the strain in the hydrogel after displacement reaches equilibrium and τ is the time 
constant, a measure of the time for the displacement to reach (1-1/e) of its total value, or 
about 63%. The values of aggregate modulus, permeability, and time constant are shown 
in Table 5.2. Cartilage had a statistically significant (p<0.05) higher aggregate modulus 
than the hydrogel samples, though they were on the same order of magnitude. The 
permeability of cartilage was significantly less than that of the hydrogels (p<0.05), except 
for the 20 wt%/10vol% EA hydrogel. There were no statistically significant differences 
in the aggregate modulus or permeability between the remaining sets of hydrogels, 
despite differences in composition and porosity. All samples tested, including cartilage, 
had similar time constants, further indicating similar creep behavior.  
 
Much like cartilage, hydrogels conform to a biphasic, viscoelastic model, where the 
relatively chemically inert, cross-linked PVA–PVP polymer constitutes an elastic solid 
phase and water within the pores comprises a moveable, incompressible fluid phase 
[237]. The solid component of cartilage and of the PVA–PVP hydrogel does have some 
viscoelastic properties, and the biphasic poroviscoelastic theory was proposed by Setton 
et al. to more accurately model the mechanical behavior [238]. However, the viscoelastic 
behavior of cartilage is due mainly to drag resulting from fluid flow through the matrix, 
which parallels properties of hydrogels, and the biphasic theory describes its behavior 
reasonably well [9, 239]. Exponential decay functions were also fitted to the data to more 
directly describe the creep behavior. The time constants for all the materials tested, 
including cartilage, were not different. Among the different compositions of the 
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hydrogels, the aggregate modulus, permeability and time constant were fairly constant, 
indicating similar creep behavior. An increase in porosity was expected to increase 
permeability and decrease aggregate modulus. However, the increase in porosity was the 
result of increasing concentration of the organic phase, and the permeability decreased 
with this increase in organic nature. The relationship shown between these parameters 
may also be affected by additional factors contributing to the fluid dynamics through the 
hydrogel, such as pore interconnectivity and pore tortuosity. These results may suggest 
that the increase in pore volume is not matched by an increase in pore interconnectivity 
and/or a decrease in pore tortuosity, which would result in an increase in permeability 
and decrease in aggregate modulus. If the increase in porosity is not accompanied by an 
increase in interconnectivity, some of the pores could be thought of as lone voids, and 
would not be useful for cell migration purposes until adjacent PLGA microparticles 
degraded, creating an interconnected porous structure.  
 
Based in part on the interconnectivity and broad size distribution of the pores, fluid flow 
within the hydrogel network is dependent on the mechanical loading and permeability of 
the tissue [237, 240, 241]. Thus, the permeability of fluid through the scaffold represents 
a structure-function link between porosity and mechanical properties. Due to the 
avascular nature of articular cartilage, diffusion of nutrients and permeability of fluid 
through the extracellular matrix are essential for sustained cell viability [38]. The pore 
size, pore morphology and interconnectivity are interrelated and influence the 
permeability of fluid through a scaffold as well as its mechanical properties [242]. Full 
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integration of a biomaterial would require properties similar to native cartilage with 
respect to fluid dynamics, in addition to mechanical integrity [243].  
 
The results show that although the hydrogels behave similarly to articular cartilage, they 
are not as stiff, and cannot be expected to fully transfer loads if implanted into a cartilage 
defect. One option to increase the compressive modulus of the hydrogels is to increase 
the concentration of PVA in the hydrogel solution. Holloway et al. [unpublished data] 
showed that the compressive moduli of nonporous PVA hydrogels prepared by the 
freeze-thaw method increase dramatically with PVA content to values above those of 
articular cartilage. It stands to reason the increasing the concentration of PVA in the solid 
phase of the superporous hydrogels would similarly increase the compressive modulus. 
This was true (data not shown), but the increase in PVA concentration caused such 
drastic decreases in hydrogel porosity that it was not useful for this application. 
 
The inverse relationships between porosity and Young’s modulus and between 
permeability and aggregate modulus indicate that decreasing the porosity and the 
permeability of the hydrogels would cause corresponding increases in Young’s and 
aggregate moduli. Thus, if cartilage does form in the pores of the hydrogel, which is 
important for integration with surrounding tissue, the ‘decrease’ in porosity is expected to 
compensate for reductions in stiffness. Similarly, the reductions in permeability that 
would result from the presence of the sulfated proteoglycans in cartilage would cause a 
corresponding increase in aggregate modulus. Further experiments are required to 
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determine the effects of cartilage formation within the pores of the hydrogels on the 
resultant mechanical properties. 
 
5.4. Conclusions 
 
The mechanical properties of the hydrogels, measured in uniaxial unconfined static 
compression, equilibrium stress-relaxation, and confined creep, were similar to articular 
cartilage. Values of modulus were inversely proportional to porosity, and permeability 
was inversely proportional to aggregate modulus. Increases in PLGA content caused 
corresponding decreases in permeability to water and increases in aggregate modulus. 
Understanding of the relationships between hydrogel structure and mechanical properties 
will allow more rational design of the hydrogels to match the tissue of interest.  
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Table 5.1. Compressive moduli of hydrogels determined from unconfined, uniaxial 
compression. 
     Compressive modulus (MPa) 
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Table 5.2. Aggregate modulus (HA), permeability (k), and time constant (τ), determined 
from confined creep tests, for the hydrogels and mature cartilage. 
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Figure 5.1. Representative stress-strain curves of hydrogels tested in uniaxial unconfined 
compression. 
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Figure 5.2. Inverse relationship between elastic modulus, determined in unconfined static 
compression, and porosity, determined using ESEM images and the program ImageJ, for 
hydrogels prepared using the Direct Incorporation method with DCM. 
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Figure 5.3. Representative equilibrium stress-strain curves for 10% PVA-PVP hydrogels 
prepared without PLGA tested in steps of stress-relaxation. 
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Figure 5.4. Relationship between Young’s modulus, determined in equilibrium stress-
relaxation, and porosity, determined from ESEM images using the ImageJ program. 
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Figure 5.5. Comparison of values of compressive modulus calculated from simple 
compression and from equilibrium stress-relaxation (n=4). 
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Figure 5.6. Strain vs. time for hydrogels tested in a confined, uniaxial creep test, for 
cartilage and a representative sample, determined from the biphasic theory through two-
parameter nonlinear regression fits. 
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Chapter 6: Characterization of the swelling behavior of superporous hydrogels in 
model systems 
6.1. Introduction 
 
The ability for hydrogels to swell and imbibe large amounts of water influences the 
scaffold’s material properties including permeability to water, solute diffusion through 
the hydrogels, degradation rate, fluid flow, and nutrient/waste exchange [7, 16]. 
Consequently, knowledge of hydrogel swelling characteristics is critical to the 
development of a successful material for biomedical engineering applications.  
 
The semi-degradable nature of the hydrogels makes their swelling behavior dynamic; as 
the degrading microparticles leave behind pores and acidic degradation byproducts, the 
hydrogel swelling is expected to increase. Changes in swelling behavior are also expected 
to correlate with changes in hydrogel structure and properties. In this study, hydrogels 
fabricated using the Direct Incorporation method were immersed in PBS to evaluate their 
dynamic swelling properties in aqueous conditions. PBS can also be used as a simplified 
model of cell culture media, although the presence of serum proteins can have significant 
effects on hydrogel swelling behavior [244, 245]. 
 
Hydrogels swell or shrink in hypotonic or hypertonic solutions due to osmotic pressure 
differences [246], and the osmotic pressure of cartilage is one of the highest in the body 
[66, 69]. Because of the dependence of hydrogel properties on their swelling 
characteristics, it is essential to know the swelling behavior of hydrogels implanted in 
107  
 
environments with high osmotic pressures, such as those generated by the proteoglycans 
found in tissues. However, the osmotic pressure generated by the ions in PBS solution is 
different from the pressure generated by macromolecules in cartilage [69]. Therefore, it is 
necessary to develop a better model than a salt solution to elucidate the swelling behavior 
of hydrogels when implanted in tissues of high osmotic pressures.  
 
The hydrogels were characterized in terms of their swelling characteristics, porosity, and 
mechanical capabilities, important properties for biomedical engineering applications. 
The behavior of the hydrogels was examined ex vivo by implantation in explanted bovine 
knees and compared to their immersion in a solution that was osmotically conditioned to 
have a similar osmotic pressure as cartilage. As PLGA hydrolytically degrades into lactic 
and glycolic acid, the internal swelling pressures of the hydrogels change, allowing a 
dynamic analysis of the swelling behavior resulting from osmotic pressure differences. 
The results are contrasted with swelling in PBS.  
 
6.2. Methods 
6.2.1. Hydrogel fabrication 
 
Hydrogels were prepared using the methods described in Section 4.2.2 in Specific Aim 1. 
For characterization of the dynamic structural changes of semi-degradable hydrogels over 
time in aqueous conditions, hydrogels were prepared with 0, 30 or 60wt% PLGA using 
the Direct Incorporation Method, in which PLGA microparticles were formed within 
PVA hydrogels in a double emulsion. For analysis of model osmotic systems, hydrogels 
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were prepared with 0, 20, or 40wt% PLGA with respect to the total polymer content 
using the Suspension Method, in which PLGA microparticles were pre-formed and 
subsequently embedded in hydrogels. 
 
6.2.2. Characterization of dynamic structure in aqueous conditions 
6.2.2.1. Analysis of swelling behavior and degradation over time 
 
The effects of the hydrogel composition and structure on initial swelling properties were 
evaluated by measuring the water content of the hydrogels after 3 days of swelling in 
PBS at 37°C (n=9). The water content is defined as the ratio of the dry mass of the 
hydrogel to the wet mass subtracted from unity. 
 
The swelling behavior of the hydrogels and degradation of the PLGA phase over 8 weeks 
in aqueous conditions were characterized for hydrogels containing 0, 30, and 60wt% 
PLGA prepared with 0, 35 and 35vol% DCM, respectively. Samples were immersed in 
PBS, which was changed every 2-3 days and maintained at 37°C. Samples (n=5) were 
removed at 2 days, 1 week, and every week thereafter. The samples were weighed, 
dehydrated, and weighed again. The swelling ratio is defined as the ratio of the mass of 
the swollen hydrogel to the mass of the dehydrated sample. After 4 weeks and 7 weeks, 
samples were dehydrated through an ethanol series, dried by critical point drying, and 
analyzed by µCT for porosity and pore size, as described in Specific Aim 1 (n=3). 3-D 
models were also constructed to qualitatively assess interconnectivity. 
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6.2.3. Development of model osmotically conditioned system 
6.2.3.1. Ex vivo implantation 
 
Knees from immature calves were obtained from a local abattoir. Full-thickness discs of 
articular cartilage, each 6 mm in diameter, about 4mm in height, and extending into the 
subchondral bone, were excised from the femoral condyles of immature bovine knees. 
These discs were weighed, dehydrated, and weighed again to obtain the swelling ratio 
and water content of the cartilage. Hydrogel discs of the same size as the cartilage discs 
(n=4) were weighed and then implanted into the defects by pres-fitting, and the knees 
were closed, wrapped in plastic, and stored in a humid room at 37°C for 5 days. After 
ensuring that the hydrogels had remained within the defects, they were removed and 
weighed again. The dry masses were recorded after dehydration. 
  
6.2.3.2. Swelling studies in model osmotic solution 
 
To examine the changes in hydrogel properties over time in an osmotic environment, the 
hydrogels were placed in dialysis tubing (nominal molecular weight cut-off of 3,500, 
Fisher, Pittsburgh, PA), secured at both ends by dialysis clips, and immersed in a solution 
of PEG in PBS. The PEG solutions were made to an osmotic pressure of 0.95atm by 
dissolving 92.3g of PEG in 1L of PBS, determined according to the equation [69]: 
      (6.1)
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where Π is osmotic pressure, R is the gas constant, T is absolute temperature, M2 is the 
molecular weight of the polymer, c2 is the concentration of the polymer, and B and C are 
the second and third virial coefficients, which are 2.59 x 10-3 and 13.5 x 10-3, 
respectively, for PEG 20,000.  
 
The hydrogels were immersed in large volumes of swelling media, at least 100 times the 
hydrogel volume, so that changes in the hydrogels’ water content did not significantly 
alter the osmotic pressure of the PEG solution. The results from this swelling study were 
contrasted with those of the hydrogels immersed in PBS.  
 
At each timepoint, cross-sections of the hydrogels were examined using ESEM and 
ImageJ for porosity calculations, as described in Specific Aim 1. Hydrogels (n=6) were 
also weighed and mechanically tested. The samples were then dehydrated and weighed 
again to determine the swelling ratio Q, the ratio of wet mass to dry mass, at each 
timepoint. 
  
6.2.4. Mechanical testing 
 
The cylindrical hydrogel samples (n=6), about 8-12mm in diameter, were sliced to ensure 
flat surfaces and thicknesses of 3-5 mm. Unconfined, uniaxial compression was applied 
using the methods described in Specific Aim 1. 
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6.2.5. Statistical Analysis 
 
One way analysis of variance (ANOVA) tests were conducted at a 95% confidence 
interval. Tukey’s test at 5% error rate was performed to compare multiple groups 
simultaneously when differences were found through ANOVA. In all figures, error bars 
represent ± 1 standard deviation, and statistical significance is defined as p<0.05. 
 
6.3. Results & Discussion 
6.3.1. Analysis of swelling behavior in aqueous conditions 
 
The degradation of the PLGA phase within the PVA hydrogels in aqueous conditions can 
be tracked by measuring their swelling ratio, the ratio of the swollen mass to the dry 
mass, over time in aqueous conditions (Fig. 6.1). PLGA degrades into lactic acid and 
glycolic acid, increasing the swelling pressure of the hydrogels and resulting in an influx 
of water from the swelling medium. There were no differences in swelling due to PLGA 
content until 2 weeks, when the hydrogels prepared with 60wt% PLGA were less swollen 
than hydrogels containing 0 or 30wt% PLGA (p<0.05). The swelling ratios of the 
hydrogels with 60wt% PLGA then increased past those of the other groups, and were 
significantly greater than hydrogels without any PLGA for the remainder of the study 
(p<0.05). Interestingly, the swelling ratios of hydrogels prepared with 30wt% PLGA 
were not different from hydrogels containing no PLGA until 7 weeks, when they were 
higher. Moreover, there were no differences between hydrogels prepared with either 
amount of PLGA at all times in the study except at 4 weeks and 5 weeks, when the 
swelling ratios of hydrogels with more PLGA were higher.  
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Swelling also increases as the PLGA degrades into acid byproducts, causing an increase 
in internal swelling pressure and a resultant influx of water [247]. Though the values of 
swelling ratio were fairly low at the beginning of the study, they reached 6-8 after 7 
weeks in PBS, levels of swelling that have been shown to be beneficial for 
chondrogenesis [159]. 
 
As the PLGA microparticles degraded within the nondegradable hydrogels, the porosity 
of the hydrogels increased, visualized by ESEM images of the cross-sections (Fig. 6.2). 
These increases in porosity were only statistically significant for hydrogels prepared with 
30wt% PLGA (p<0.05) (Fig. 6.3). Interestingly, the porosity of hydrogels prepared 
without PLGA actually decreased over 7 weeks in aqueous conditions, as the PVA phase 
swelled and constricted the pores. The average pore size decreased slightly over 7 weeks 
for hydrogels prepared without PLGA (Fig. 6.4) (p>0.05), but increased significantly for 
hydrogels prepared with 30wt% PLGA and 60wt% PLGA (p<0.05). An analysis of the 
pore size distribution of the hydrogels provided further insight into the changes. The 
pores in hydrogels prepared without PLGA shrunk over time, represented by a shift of the 
curve to the left (Fig. 6.5). In contrast, the pores of the hydrogels prepared with 30 or 
60wt% PLGA became larger, represented by shifts of the pore distribution curves to the 
right (Fig. 6.6 and 6.7).  
 
Three-dimensional models of the hydrogels were constructed using µCT at 0 and 7 weeks 
of swelling in PBS in order to qualitatively assess interconnectivity of the pores (Fig. 
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6.8). The pores of hydrogels prepared without PLGA appeared to be less connected than 
those of hydrogels prepared with 30 or 60wt% PLGA. The pores of the hydrogels with 
PLGA appeared to increase in size, number, and interconnectivity after 7 weeks in PBS. 
 
In this system, the PLGA microparticles degraded over time by hydrolysis within the 
PVA hydrogels, forming new pores in the network, increasing the size of existing pores, 
which would presumably create more room for cartilage tissue to grow.  
 
6.3.2. Validation of model osmotically conditioned system 
6.3.2.1. Ex vivo implantation 
 
Swelling in PBS provides analysis of changing hydrogel properties with degradation, and 
while it is an adequate albeit over-simplified model of cell culture media, it cannot 
approximate the osmotic pressures found in articular cartilage. The osmotic pressure of a 
simple salt solution is also different from that of macromolecules in solution [69]. 
Hydrogels shrink or swell in hypertonic or hypotonic solution, respectively, so a model 
system with the osmotic pressure of cartilage is necessary for biomaterial swelling 
analysis. 
 
The swelling properties of the hydrogels were examined when implanted into knee 
articular cartilage, an environment with a high osmotic pressure. First, hydrogels 
prepared without microparticles were implanted into defects created in bovine knees, and 
their swelling ratios were determined after five days (Fig. 6.9). The swelling ratios after 
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five days ex vivo were significantly reduced to around half of the initial values and the 
water contents decreased from 86% to 74%, indicating a large degree of shrinkage 
(p<0.05).  The changes in swelling ratio were compared with immersion in osmotic 
solution for five days. The osmotic pressure for this swelling medium was chosen to be 
0.95atm, because it is in the middle of the range reported in the literature for cartilage 
[65, 69]. This osmotic pressure was achieved by dissolving PEG in PBS at a 
concentration determined by Urban et al. [69]. 
 
After five days in a PEG solution with an osmotic pressure in the range of cartilage, the 
hydrogels also experienced a large decrease in water content. This reduction in swelling 
ratio in the PEG solution was not significantly different from the behavior in cartilage. 
The swelling ratio of cartilage was 3.93 ± 0.595 and was not significantly different from 
the swelling ratio of the hydrogels either implanted for 5 days ex vivo or immersed in 
PEG solution, suggesting that the osmotic pressure of the hydrogels equilibrated to their 
surroundings (Fig. 6.9). 
 
 This study suggests that a PEG solution could be used to determine changes in hydrogel 
properties due to the osmotic pressure gradient without resorting to costly in vivo studies. 
The changes influence a hydrogel’s mechanical properties, permeability to water, drug 
release profiles, and ability to support cell ingrowth or viability. In addition, the fact that 
the swelling properties of the hydrogels reached those of the surrounding tissue points to 
a potential use of PEG as a conditioning system to cause the swelling properties of an 
implant to equilibrate to a desired value prior to implantation. 
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This model of an in vivo system does have several limitations. A cartilage implant will 
experience more forces in vivo than those exerted by osmotic pressure alone, such as 
mechanical loading, in addition to biochemical signaling and cellular factors influencing 
hydrogel swelling. Furthermore, articular cartilage is a complex tissue, and the water 
content, swelling ratio, and osmotic pressure vary significantly with depth. When 
implanted into a tissue, cells and proteins and other large molecules could potentially 
infiltrate the material, which would affect the swelling properties. In this study, however, 
the hydrogels immersed in PEG solution were placed in dialysis tubing to prevent PEG 
molecules from penetrating the hydrogels, so that the effects of osmotic pressure on the 
hydrogels alone could be isolated. In addition, the ex vivo environment, in the absence of 
any fluid flow resulting from mechanical loading, does not perfectly depict the in vivo 
environment. Despite the model’s shortcomings, however, immersion in the PEG 
solution did reasonably predict the large changes in degree of swelling and water content 
as shown by the ex vivo implantation. 
 
6.3.3. Swelling behavior in model osmotically conditioned system 
6.3.3.1. Changes in hydrogel microstructure 
 
To gain a more complete understanding of the changes in hydrogel properties when 
implanted in an osmotic environment, the samples were immersed in PEG solution for 6 
weeks. To examine the effects of changing internal osmotic pressures, microparticles 
were incorporated into the hydrogels in the amounts of 20 and 40wt%. ESEM images of 
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hydrogel cross-sections, which initially had a large amount of interconnected pores 
around 10-200 µm in diameter, indicate that the porosity of the hydrogels prepared with 
microparticles decreased substantially after 4 weeks in PEG solution, in that the pores 
were fewer, smaller, and not interconnected. In contrast, the porosity of the hydrogels 
remained high after 4 weeks in PBS (Fig. 6.10). The values of porosity are shown for the 
hydrogels prepared with microparticles after 1 week and 4 weeks in PBS or PEG solution 
(Fig. 6.11). The porosity of hydrogels prepared without microparticles was zero, and did 
not increase throughout the course of the experiment. The porosity of the hydrogels 
prepared with 20wt% microparticles did not change over 1 week in PBS or in PEG 
solution, but it did significantly increase after 4 weeks in PBS and decrease after 4 weeks 
in PEG. The porosity after 4 weeks in PEG was significantly lower than that after 4 
weeks in PBS. The porosity of the hydrogels prepared with 40wt% microparticles did not 
change over 4 weeks in PBS, but it did significantly decrease after just 1 week in PEG 
solution. The porosity of the hydrogels made with 40wt% microparticles was 
significantly lower after both 1 week and 4 weeks in PEG solution than it was in PBS 
(p<0.05). 
 
The porosity of tissue engineering scaffolds affects the material’s ability to encourage 
cellular infiltration, migration, and proliferation [108, 228, 231]. Because the PLGA 
microparticles degrade hydrolytically, they were expected to degrade under physiological 
conditions, creating more pores in the non-degradable hydrogel matrix and increasing the 
porosity of the hydrogels over time. When the hydrogels were immersed in PBS for 4 
weeks, the porosity did increase (Fig. 6.10 and 6.11). However, when the hydrogels were 
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immersed in PEG solution, the porosity decreased. The hydrogels appeared to collapse on 
the porous network after 4 weeks in osmotic environment, which has obvious 
implications for tissue engineering applications.  
 
6.3.3.2. Changes in swelling behavior 
 
Reductions in porosity were accompanies by reductions in swelling ratio. For hydrogels 
with 20 or 40wt% microparticles, the swelling ratio decreased significantly after just 1 
week in PEG solution (Fig. 6.12). The swelling ratio of the hydrogels prepared with no 
microparticles decreased further after 2 weeks, but then remained at that value for the 
duration of the experiment. The swelling ratio of the hydrogels with 20wt% 
microparticles was slightly reduced from 1 to 4 weeks, and that of the hydrogels with 
4wt% microparticles was slightly reduced from 2 to 4 weeks. From 4 to 6 weeks there 
were no significant differences for any of the hydrogels.  
 
The swelling behavior of the hydrogels in osmotic solution was compared to the behavior 
in PBS (Fig. 6.12). The swelling ratio of the hydrogels without microparticles decreased 
after 1 week in PBS and remained level until it decreased again at 6 weeks. The 
hydrogels with 20wt% microparticles saw a decrease in swelling ratio after 1 week, but 
then significant increases in swelling ratio through 4 weeks, where it remained level. The 
swelling ratio returned to its original value after 3 weeks. The swelling ratio of the 
hydrogels with 40wt% microparticles decreased after 1 week in PBS, but then increased 
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at every timepoint thereafter until 4 weeks. The swelling ratio returned to its original 
value after 2 weeks. 
 
The changes in swelling ratios of the hydrogels over 6 weeks in osmotic solution and in 
PBS provides a detailed description of the swelling behavior (Fig. 6.12). After 1 week 
immersed in PEG solution, all sets of hydrogels experienced a sharp decrease in swelling 
ratio, which then either remained the same or decreased further through the remainder of 
the experiment. By the sixth week, there was no difference in swelling ratio between the 
hydrogels with different amounts of microparticles, further indicating that hydrogel 
matrix collapsed on the pores left by the degrading microparticles. The hydrogels 
responded to the osmotic pressure gradient with the expulsion of water. This behavior 
was expected since hydrogels shrink readily in hypertonic solution. These samples also 
experienced a slight reduction in swelling ratio and water content after 1 week in PBS. 
This behavior has been previously documented, and is attributed to the relaxation 
behavior of the hydrogels [187].  
 
After 1 week in PBS, the swelling ratio of the hydrogels prepared without microparticles 
did not change, but the swelling ratios of the hydrogels prepared with microparticles 
gradually increased. The increased swelling can be attributed to increases to the ionic 
contribution to osmotic pressure, as the PLGA microparticles break down to lactic and 
glycolic acid. At the end of the study, the hydrogels with the highest amount of initial 
microparticle loading had the highest swelling ratio, followed by the hydrogels with the 
lower amount of initial microparticles, and the hydrogels prepared without microparticles 
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had the lowest swelling ratio, a reverse from their initial relationships. The behavior of 
the hydrogels with changing osmotic pressures, those prepared with microparticles, 
further indicate how the swelling is influenced by osmotic pressure differences. As the 
internal osmotic pressures of the hydrogels increased, they took up more water from the 
surrounding environment, and the amount of water was related to the amount of initial 
microparticle loading.  
 
The swelling behavior of the hydrogels immersed in PBS was very different from 
“swelling” in cartilage or in PEG solution. According to traditional theory of osmotic 
pressure of salt solutions, the osmotic pressure of a salt solution can be calculated by the 
equation , where cs is the molarity of the solute and i is the van’t Hoff factor, 
or the number of moles of solute in solution, which is 2 for NaCl [248]. This equation 
gives PBS, which is approximately 0.15 M NaCl, an osmotic pressure of over 7atm. The 
ions in PBS can move freely into the hydrogels, quickly reducing the difference between 
osmotic pressures of the hydrogels and of the surrounding solution. The macromolecules 
dissolved in a PEG solution cannot move as freely and are separated from the hydrogels 
by dialysis bags, so that the effective osmotic pressure remains high throughout the 
duration of the swelling study. This distinction accounts for the large difference between 
the swelling behavior of hydrogels immersed in PBS and in PEG solution. 
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6.3.3.3. Changes in mechanical properties 
 
For hydrogels with 20 or 40wt% microparticles, the values of elastic modulus 
significantly increased after 4 weeks in PEG solution (p<0.05) (Fig. 6.13). The moduli of 
the hydrogels with no microparticles and with 40wt% microparticles increased after just 
one week in PEG solution. For the hydrogels swelling in PBS, the moduli remained the 
same, or decreased at 4 weeks, in the case of the hydrogels with 40wt% microparticles. 
The values of elastic modulus were significantly higher for the hydrogels immersed in 
PEG solution for 4 weeks than those immersed in PBS for 4 weeks, except for the 
hydrogels with 20wt% microparticles. These values are similar to the elastic moduli of 
articular cartilage found in the literature, further indicating a use of PEG solutions as a 
conditioning system for implants [58]. The mechanical properties of implants are 
especially important in orthopedic applications, which are also where the tissue osmotic 
pressures are the highest [65, 108, 231].  
 
The drastic changes in material properties of the hydrogels in an osmotic environment 
can provide insight into parameters to be considered in the design of biomaterials or 
tissue engineering scaffolds. Obviously a biomaterial should not shrink or swell to a great 
extent following implantation, so the property of resistance to osmotic forces should be 
investigated. The effects of changing properties on cellular response should also be 
considered. Unexpected changes in the swelling properties of hydrogels can lead to a lack 
of material success. For example, PVA hydrogels, also prepared by the freezing and 
thawing technique that were implanted into the intervertebral discs of baboons, were 
found to have shrunk at the time of retrieval, resulting in a high rate of extrusion [249]. 
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The authors noted that the osmotic pressure of the baboon disc is higher than that of 
humans, causing the hydrogels to shrink more than expected. On the other hand, several 
investigators have sought to exploit the swelling properties of hydrogels. The prosthetic 
disc nucleus (PDN) is composed of a hydrogel core surrounded by a polyethylene layer, 
and absorbs up to 80% of its weight in water following implantation into the disc cavity, 
so that it swells and fills the void space [250]. Based on the desired ending mechanical 
properties, the material was re-designed to change the amount of water absorbed from the 
disc nucleus cavity. Similarly, Sakkers et al. presented hydrogels based on poly(ethylene 
oxide) and poly(buthylene terephtalate) (Polyactive®) as bone implants [251]. These 
materials absorb water and expand following implantation to achieve close bone-polymer 
contact. The authors compared this expanding material to pre-swollen implants, which 
shrank in vivo. Thus, not only is the high osmotic pressure of tissues an important design 
consideration for biomaterials, it can be exploited to enhance the space-filling capacity of 
hydrogels.  
 
The PEG solution provides an approximation for the swelling behavior of hydrogels in 
cartilage. However, the gradient of osmotic pressure found in native tissues cannot be 
duplicated with a PEG solution, nor can the complex milieu of mechanical and 
biochemical signals be replicated, so it cannot be a perfect model. In general, PVA-PVP 
hydrogels with and without PLGA microparticles experienced reductions in porosity and 
swelling ratio, and increases in elastic modulus upon immersion in PEG solution. This 
behavior was different from that in PBS, indicating a deficiency in the use of PBS as a 
means of analysis of the in vivo environment. Characterization of dynamic swelling 
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behavior of hydrogels in aqueous conditions is important. However, conflicting 
information exists regarding the differences between hydrogel swelling behavior in cell 
culture media or in PBS, with some studies reporting differences [244] and others 
reporting no differences [245]. Swelling studies should be designed to examine the 
behavior of hydrogels in the intended environment. 
 
6.4. Conclusions  
 
The porosity, average pore size, and swelling behavior of semi-degradable hydrogels 
increased as the microparticles degraded in PBS. These changes in structure will provide 
insight into the behavior of cells within the hydrogels. For example, increases in 
extracellular matrix deposition may be associated with increased porosity. Future studies 
should evaluate these changes so that hydrogel design can be dictated by the desired 
effects on encapsulated cells. 
 
A solution of PEG was also presented as a model osmotically conditioned system, and 
can be used to approximate the osmotic pressure of native tissues in order to elucidate the 
swelling behavior of a potential biomaterial in vivo. Although the model has some 
limitations, it can successfully show the significant changes experienced by hydrogels 
residing in an osmotic environment. Response to osmotic forces is a parameter that must 
be considered in the design of biomaterials. Finally, the ability of a PEG solution to be 
used as an osmotic conditioning system for materials prior to implantation should be 
investigated in the future. 
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Figure 6.1. Swelling ratio, the ratio of wet mass to dry mass of the hydrogels, over time 
immersed in PBS at 37°C. 
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Figure 6.2. Representative ESEM images of hydrogels prepared with 0, 30, and 60wt% 
PLGA after 3 days, 4 weeks, and 7 weeks in PBS at 37°C. 
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Figure 6.3. Porosity of hydrogels prepared with 0, 30, or 60wt% PLGA after 0, 4, and 7 
weeks in PBS at 37°C. 
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Figure 6.4. Average pore size, measured using µCT, of hydrogels before and after 7 
weeks of swelling in PBS at 37ºC (n=3, *p<0.05).
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Figure 6.5. Distribution of pore sizes, measured using µCT, for hydrogels prepared with 
0wt% PLGA after 0, 4, and 7 weeks in PBS at 37°C. (n=3) 
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Figure 6.6. Distribution of pore sizes, measured using µCT, for hydrogels prepared with 
30wt% PLGA after 0, 4, and 7 weeks in PBS at 37°C. (n=3) 
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Figure 6.7. Distribution of pore sizes, measured using µCT, for hydrogels prepared with 
60wt% PLGA after 0, 4, and 7 weeks in PBS at 37°C. (n=3) 
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Figure 6.8. Virtual 3D models, constructed using micro-computed tomography (µCT), of 
hydrogels prepared with 0, 30, and 60wt% PLGA after 0 and 7 weeks in PBS at 37°C. 
Scale bars are 100µm. 
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Figure 6.9. Swelling ratios, the ratio of wet mass to dry mass, of hydrogels prepared 
without microparticles initially and 5 days after ex vivo implantation into bovine knees or 
immersion in PEG solution. 
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Figure 6.10. Representative ESEM images of cross-sections of hydrogels prepared 
without microparticles and with 20 and 40wt% microparticles initially and after 4 weeks 
immersed in PBS or in PEG. 
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Figure 6.11. Fractional porosity, determined from ESEM images and the program 
ImageJ, of hydrogels initially and after 1 and 4 weeks in PBS and in PEG solution. 
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Figure 6.12. Swelling ratios over time immersed in PBS and in PEG solution.  
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Figure 6.13. Compressive moduli of hydrogels, determined from unconfined, uniaxial 
compression, of the hydrogels initially and after 4 weeks in PBS and in PEG solution 
(n=6, p<0.05). 
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Chapter 7: Analysis of the effects of hydrogel properties on chondrogenesis 
7.1. Introduction 
 
Though PVA hydrogels have been studied extensively as cartilage replacement materials 
for over 40 years because of their ideal mechanical properties, their lack of integration 
with the surrounding tissue has impeded their usefulness. In order to employ PVA 
hydrogels as cartilage replacements, they must possess the ability to integrate with 
surrounding cartilage, in addition to adequate mechanical properties, so that the loads are 
efficiently transferred and the repair tissue is stable. Because cells cannot attach to 
hydrophilic polymers like PVA, they are bio-inert and cannot interact with surrounding 
tissue [23].  
 
This lack of adhesiveness also makes chondrogenesis difficult in PVA hydrogels, because 
chondrocytes require some degree of attachment in order to secrete ECM components 
[234] and to allow integrin-mediated mechanotransduction, an important aspect of 
cartilage metabolic regulation [252]. On the other hand, chondrocyte spreading and 
attachment can be indicative of de-differentiation and a loss of the chondrocyte 
phenotype. Moreover, some researchers have attempted to modify PVA hydrogels with 
adhesive cell-surface proteins such as fibronectin [252], a strategy that may cause too 
much adhesion and may result in a reduction in chondrogenesis, although conflicting 
information abounds [253-255]. Research suggests that there exists an optimal level of 
adhesion that allows mechanotransduction without causing a reduction in chondrogenesis 
[234]. On the other hand, chondrocytes attach to degradable aliphatic polyester scaffolds 
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like PLGA at an ideal level, and implants of regenerated cartilage based on these 
scaffolds integrate successfully with surrounding cartilage [107]. It is hypothesized that 
by incorporating a phase of PLGA throughout a porous hydrogel network, chondrocytes 
will fill the pores of the hydrogel with cartilage tissue that would facilitate integration 
with surrounding cartilage. 
 
A few other researchers have also attempted to combine the advantages of both 
biodegradable scaffolds and hydrogels. Park et al. combined PEG hydrogels with 
poly(caprolactone) (PCL) and found that the cell adhesiveness of PCL and the structural 
properties of PEG had synergistic effects, improving chondrogenesis over either PEG or 
PCL scaffolds alone [256]. Mohan et al. presented promising preliminary results of 
chondrocytes seeded within porous PVA hydrogels that contained PCL, but the 
effectiveness of cell seeding and the distribution of cells were not characterized [257]. 
Gong et al. filled PLLA scaffolds with chondrocyte-containing agar and gelatin and 
achieved greater chondrogenesis than PLLA scaffolds alone, on which chondrocytes 
became fibroblastic [258]. Though the mechanical properties were inappropriate for 
cartilage mimesis, the level of proteoglycans and cartilage synthesis were greater than 
PLLA scaffolds or agar hydrogels alone. 
 
In this work, chondrocytes were seeded into superporous hydrogels for analysis of the 
ability of the hydrogels to support cartilage formation. The effects of various hydrogel 
properties, such as PLGA content and swelling ratio, on chondrocyte adhesion and in 
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vitro chondrogenesis were evaluated. The effects of internal cartilage formation on the 
mechanical properties of the hydrogels were also studied in vitro. 
 
7.2. Methods 
7.2.1. Adhesion studies 
 
Chondrocytes were isolated from the knee joints of 1-week old pigs by collagenase 
digestion and subsequent cell straining [259]. Chondrocytes were cultured in vitro for one 
week in Dulbecco’s Modified Eagle Medium (DMEM) containing 4.5g/L glucose, 10mM 
sodium pyruvate, 25mM HEPES buffer, 10% fetal bovine serum, and 1% 
antibiotic/antimycotic solution (Invitrogen, Carlsbad, CA). After one week of cell 
expansion, the chondrocytes were collected from the trays by trypsinization and cell 
scraping. The cells were then added to the surfaces of hydrogels (n=5 per group) in 50µl 
suspensions containing 2.5 million cells. The hydrogels were cultured with this cell 
suspension for 4 hours at 37ºC and 5% CO2 before adding cell culture media. As a 
control, cell suspensions were also added to 24-well tissue culture polysytrene trays. The 
cell-seeded hydrogels were cultured in vitro overnight, and then washed with cell culture 
media to remove nonadherent cells. This supernatant was saved for cell counting. The 
samples were removed from their trays, which were then trypsinized and washed to 
collect any cells that had moved from the hydrogels to the surrounding well plate, which 
may have occurred during the initial addition of cell culture media. These cells were 
added to the same tube containing the cells that were removed from the trays, and the 
entire cell suspension was counted for each sample. The number of cells in each tube was 
139  
 
considered the number of cells that did not adhere to the hydrogels, so this number was 
subtracted from the initial seeding concentration (2.5 million) to calculate the number of 
adherent cells.  
 
Three different hydrogel properties were investigated for their effects on chondrocyte 
adhesion. First, the effects of porosity were investigated by seeding chondrocytes on 
hydrogels prepared without PLGA and with either 0 or 10vol% DCM, which had values 
of porosity of 0 and 62.7±6.57%, respectively. To evaluate the effects of PLGA content, 
chondrocytes were seeded on hydrogels that were prepared with 0, 30, and 60wt% PLGA 
that had been swelling in PBS at 37ºC for 3 days. Finally, the effects of swelling ratio 
were investigated by seeding chondrocytes on hydrogels that were prepared with 60wt% 
PLGA and that had been swelling in PBS at 37ºC for 0 hours (dry), 2 hours, or 3 days. 
 
7.2.2 Analysis of chondrogenesis in vitro 
 
Chondrocytes were isolated from the femoral condyles of immature calves (Research 87, 
Marlboro, MA) by collagenase digestion and subsequent cell straining [259]. The 
chondrocytes were seeded in T-75 cell culture flasks at a density of 6 million cells per 
flask and cultured in DMEM containing 4.5g/L glucose, 10mM sodium pyruvate, 25mM 
HEPES buffer, 10% fetal bovine serum, and 1% antibiotic/antimycotic solution 
(Invitrogen, Carlsbad, CA). After one week of cell expansion, the chondrocytes were 
collected from the trays by trypsinization and added to the dry hydrogels prepared with 0, 
30, or 60wt% PLGA using the Direct Incorporation method in 100µl suspensions 
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containing 5x106 cells. The hydrogels were prevented from floating by surrounding them 
with a thin layer of silicone elastomer gel (Sylgard-184, Auburn, MI), which also allowed 
unattached cells to be easily removed. The cell-hydrogel constructs were cultured at 37°C 
in 5% CO2, and the media was changed every other day.  
 
7.2.2.1. Analysis of cell-seeding efficiency 
 
After 3 days of cell culture, the efficiency of cell-seeding was determined by measuring 
the number of chondrocytes in the hydrogels and comparing to the number of 
chondrocytes that were added. Hydrogels (n=3) were washed with fresh media, minced, 
dehydrated by lyophilization, and digested in papain solution overnight at 65°C.  The 
papain solution was 125µg/ml papain 10mM HCl, 10mM L-cysteine, 0.1M sodium 
acetate, and 0.05M ethylenediaminetetraacetic acid (Sigma-Aldrich). The DNA content 
in these samples was determined using the Picogreen assay (Invitrogen) and converted to 
number of chondrocytes using the conversion factor of 7.7pg of DNA per chondrocyte 
[260]. 
 
7.2.3. Histological analysis of in vitro chondrogenesis 
 
After 3 days, 4 weeks, and 7 weeks in cell culture, the cell-hydrogel constructs (n=3) 
were fixed in 4% paraformaldehyde in PBS for 4 days, and then immersed in a 30% 
sucrose solution for 3 days to prepare for sectioning. The samples were embedded in 
freezing media, mounted on a cryostat, and sectioned to 25µm. The sections were affixed 
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to glass slides using rubber cement and analyzed for distribution of cells and 
proteoglycans by staining with hematoxylin and Safranin’O, respectively. 
 
7.2.4. Mechanical Testing 
 
After 4 weeks in culture, samples (n=3) were tested in uniaxial, unconfined compression, 
using an Instron 50N load cell in a bath of PBS, and compared to non-cell-seeded 
controls that were in DMEM for 4 weeks. Samples were also tested after swelling in 
DMEM for 3 days, as an initial value. The samples were pre-loaded to a strain of 10% 
and compressed further to 16% strain at a rate of 100% strain/minute. The slope of the 
linear stress-strain curve, taken from 12-14%, was defined as the compressive modulus.  
 
7.2.5. Statistical Analysis 
 
All values are reported as mean ± standard deviation. Statistical analysis of differences 
between groups was evaluated using a one-way or two-way analysis of variance 
(ANOVA). Differences between the means were then calculated post-hoc using Tukey’s 
test. Differences between individual treatments were analyzed using student’s t-test. 
Confidence levels for all tests were 0.05.  
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7.3. Results & Discussion  
7.3.1. Analysis of effects of hydrogel properties on cell adhesion  
 
After 4 hours following chondrocyte seeding and before the addition of cell culture 
media, all of the hydrogels still appeared wet, in contrast to the control tissue culture 
trays, which appeared to have dried significantly. From this observation, it was expected 
that the cells on the control would die as they dried out. In fact, it was impossible to 
remove cells from the trays for counting the next day because they had dried onto the 
plastic. The cell suspensions in the hydrogels, however, remained moist, because the 
hydrogels were either swollen in liquid to begin with or retained the 50ul of liquid in the 
cell suspension, unlike the tissue culture plastic control, which allowed the liquid to 
spread out from a droplet and evaporate. Nonetheless, observations regarding the effect 
of hydrogel properties on cell adhesion could still be gathered, but the actual values of the 
adherent percentage of cells are likely inflated due to errors in the measurements, such as 
inefficient collection of nonadherent cells. 
 
The introduction of porosity to hydrogels that did not contain PLGA resulted in a 
significant increase in chondrocyte adhesion (p<0.05) (Fig. 7.1), which is attributed to the 
sinking of cells into the pores of the hydrogel, as opposed to true ‘adhesion,’ considering 
it is well known that cells do not adhere to hydrophilic matrices such as PVA [23]. There 
were no differences in adhesion to hydrogels containing increasing amounts of PLGA, 
from 0 to 60wt% (Fig. 7.2), even though cells readily attach to PLGA, indicating that the 
cells sank into the scaffolds.  
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Increasing the swelling ratio of hydrogels prepared with 60wt% PLGA by immersing in 
PBS for 2 hours or 3 days resulted in a significant decrease in chondrocyte adhesion 
(p<0.05) (Fig. 7.3). The percentage of cells that adhered in the dry hydrogels was the 
highest of all the conditions tested in the experiment. It is possible that the influx of water 
due to initial hydrogel swelling contributed to the cell seeding. It is unlikely that these 
cells experienced drying effect, like they did on tissue culture plastic, because the 
hydrogels appeared wet just before the addition of cell culture media. 
 
Due to the errors associated with the positive control, it was not possible to make any 
definite conclusions about the actual numbers of cells seeded in each hydrogel. 
Therefore, studies were conducted utilizing the Picogreen assay to measure DNA content 
inside a sample, so that true values of the number of cells that were actually seeded could 
be determined.  
 
7.3.2. Analysis of cell-seeding efficiency 
 
When 5 million chondrocytes were seeded onto hydrogels containing 0, 30, or 60wt% 
PLGA, the number of cells that remained in the hydrogels after 3 days was low for all 
samples, ranging from 0.5% to 15% (Fig. 7.4). Although there were no statistically 
significant differences, there was a general trend of increasing cell-seeding efficiency 
with increasing PLGA content, and the efficiency of cell-seeding on hydrogels without 
PLGA was practically zero. Samples were also analyzed histologically after 3 days to 
ensure that cells were able to penetrate into the depths of the hydrogels, although the 
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actual distance was difficult to quantify. The lack of differences in cell seeding efficiency 
indicates that porosity has a greater influence on cell seeding than PLGA content. 
However, because the cell-seeding efficiencies were fairly low, a significant portion of 
the cells must have remained at the surface of the hydrogels, as opposed to penetrating 
into the depths of the hydrogel, and were likely washed off during the first media change. 
The cell-seeding efficiency was slightly increased with PLGA content, due to the higher 
degree of cell attachment to PLGA than to PVA, which would prevent any cells from 
being washed away [23].  
 
7.3.3. Analysis of cartilage formation in vitro 
 
After 4 weeks in cell culture, chondrocytes spread throughout the porous network of 
hydrogels containing 30 or 60wt% PLGA, but only a few clusters of cells were found on 
the surface of hydrogels prepared without PLGA (Fig. 7.5). Histological staining with 
Safranin-O revealed robust staining of proteoglycans in both sets of hydrogels containing 
PLGA, with a much greater amount visible in hydrogels that contained 60wt% PLGA. 
There were no obvious differences in staining between hydrogels cultured for 4 or 7 
weeks. Hydrogels without PLGA exhibited no proteoglycan staining.  
 
After 4 and 7 weeks in cell culture, chondrocytes remained viable and secreted sulfated 
proteoglycans throughout the pores of the hydrogels that contained PLGA. In contrast, 
only a few cells were seen at all in the hydrogels that contained no PLGA, and no 
proteoglycans were detected. Since some cell spreading is necessary for cartilage 
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formation, it was not unexpected that the increased PLGA content resulted in an increase 
in proteoglycans synthesis and that no chondrogenesis was observed in the non-adhesive 
PVA hydrogels [234].  
 
Thus, the PLGA phase of the hydrogels served to simultaneously add porosity and cell 
adhesiveness to the hydrogels, so that chondrocytes could be seeded in the hydrogels and 
stimulated to produce cartilage, which is not possible for unmodified PVA hydrogels. 
 
The success of the hydrogels that initially contained PLGA over the control gels may also 
be related to their semi-degradable nature, which is in agreement with a study by Anseth 
et al. that showed that partially degradable PEG hydrogels promoted more 
chondrogenesis than fully nondegradable gels because of increases in swelling ratio 
[159]. In this study, the quantitative level of chondrogenesis was not measured. 
Obviously, this is an important parameter that must be evaluated in future studies to 
definitively determine the suitability of this material as a cartilage tissue engineering 
scaffold. 
 
7.3.4. Relationship between cartilage formation and mechanical properties 
 
Although many of the pores of the hydrogels with PLGA were filled with cartilage-like 
tissue, it was immature and did not fill all of the pores. To examine the role of the newly 
formed extracellular matrix on the mechanical properties of the hydrogels, the 
mechanical properties of the hydrogels were measured after 4 weeks with and without 
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cells in cell culture media (Fig. 7.6). These values were also compared to initial values, 
determined after 3 days of swelling in cell culture media (without cells). Hydrogels 
prepared without PLGA were initially stiffer than those with PLGA (p<0.05), and 
hydrogels with 60wt% PLGA were initially stiffer than those with 30wt% PLGA, 
consistent with the fact that they were less porous (p<0.05). All hydrogels experienced 
increases in compressive modulus after 4 weeks in media compared to initial values, even 
without cells, though this difference was only significant for hydrogels without PLGA. 
There were no differences in mechanical properties of hydrogels cultured with or without 
cells, further indication that cartilage tissue did not fill all of the pores of the hydrogels. 
 
The compressive moduli of the hydrogels of all formulations were well within the range 
of values reported for healthy cartilage, 0.4-0.8 MPa [58]. All of the hydrogels had 
increases in compressive modulus after 4 weeks of swelling, regardless of initial PLGA 
content. These changes were particularly interesting for hydrogels that initially contained 
PLGA because they also experienced increases in porosity and water content, which 
typically result in decreases in compressive modulus [13, 247]. This increase was only 
significant for hydrogels prepared without PLGA that were in media and in cell culture 
for 4 weeks, and is likely due to their decrease in porosity and an increase in swelling 
pressure as ions and proteins from the media entered the hydrogel. The compressive 
moduli of the hydrogels cultured with chondrocytes were higher than their non-cell-
seeded controls after 4 weeks, though these changes were not statistically significant. 
Chondrogenesis within hydrogels has been shown to raise the mechanical properties of 
much weaker gels [6]. The lack of significant differences in compressive modulus after 4 
147  
 
weeks in cell culture compared to corresponding non-cell-seeded controls may indicate 
that the level of ECM in the pores was insufficient to affect the resultant mechanical 
properties, and may be a result of the relatively low number of cells that were seeded 
(less than 1 million per hydrogel). Furthermore, the increase or lack of a decrease in 
mechanical properties of hydrogels containing PLGA may be a result of increases in 
swelling pressure due to the generation of the acidic byproducts of PLGA degradation. 
An increase in swelling pressure would impede fluid flow through the hydrogels, 
increasing the apparent compressive modulus [188]. The fact that the hydrogels’ 
mechanical properties were stable despite increases in water content and swelling ratio 
may be advantageous, considering that high swelling ratios are beneficial for cartilage 
growth [159]. However, the mechanical properties of the hydrogels after 7 weeks, when 
their swelling ratios were significantly higher than at 4 weeks, were not measured, so it is 
not possible to speculate on the balance between increases in swelling pressure and 
increases in water content and porosity after 7 weeks of swelling. 
 
Tissue-specific substrate mechanics are integral to the optimal functioning of entrapped 
cells [5]. The properties of PVA hydrogels prepared by conventional crosslinking 
methods are probably the closest of any hydrogel system to healthy cartilage. In order to 
fully take advantage of the ideal mechanical properties of an implant, however, 
integration with the surrounding tissue is necessary to ensure effective load transfer. This 
study demonstrated that it is possible to cultivate cartilage tissue within the pores of a 
nondegradable hydrogel. However, future studies are required to increase the cell-seeding 
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efficiency of the hydrogels so that more chondrocytes can be incorporated, which would 
result in higher levels of cartilage formation. 
 
7.4. Conclusions 
 
Hydrogel properties, such as porosity and swelling ratio, influence cell seeding and 
adhesion, and should be considered in tissue engineering designs. Chondrocytes were 
successfully seeded throughout the hydrogels and chondrogenesis was supported over 7 
weeks in cell culture. The composition of the hydrogels, in terms of the PLGA content, 
drastically influenced the ability of the hydrogels to support chondrogenesis over 7 weeks 
in vitro. Cartilage formation was enhanced with increasing PLGA, but did not occur at all 
in hydrogels without any PLGA. The mechanical properties of all formulations remained 
stable after 4 weeks in swelling conditions. This study established the feasibility of 
cartilage formation within PVA hydrogels, which may allow the secure integration of a 
PVA-based implant. 
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Figure 7.1. Chondrocyte adhesion, expressed as a percentage of the total number of cells 
that were adherent, to hydrogels prepared with 0wt% PLGA and no DCM (non-porous) 
or with 10vol% DCM (porosity=62.7±6.57%) (n=5, *p<0.05). 
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Figure 7.2. Chondrocyte adhesion, expressed as a percentage of the total number of cells 
that were adherent, to hydrogels prepared with increasing PLGA content (n=5). 
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Figure 7.3. Chondrocyte adhesion, expressed as a percentage of the total number of cells 
that were adherent, to hydrogels prepared with 60wt% PLGA at increasing swelling 
ratios (n=5, *p<0.05).
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Figure 7.4. Efficiency of seeding chondrocytes on hydrogels prepared with 0, 30, and 
60wt% PLGA, calculated by measuring the number of chondrocytes in hydrogels after 3 
days of cell culture. 
 
153  
 
 
 
 
 
 
 
 
Figure 7.5. Representative images of histological analysis of chondrogenesis after 4 and 7 
weeks in hydrogels prepared with 0, 30, and 60wt% PLGA. Hematoxylin stains cell 
nuclei purple and Safranin’O stains sulfated proteoglycans red. Original magnification is 
200x; scale bars are 100µm. 
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Figure 7.6. Average compressive modulus, measured in unconfined, uniaxial 
compression, of hydrogels after 3 days and 4 weeks without cells in cell culture media, 
and of hydrogels with chondrocytes after 4 weeks in cell culture. (*p<0.05) 
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Chapter 8: Development of hydrogels as controlled release systems and evaluation 
of their efficacy in vivo 
8.1. Introduction 
 
Significant progress has been made in scaffold design, and seeded chondrocytes 
proliferate and produce cartilage-like tissue. However, the generation of functional 
cartilage tissue has not yet been achieved. It appears likely that modulation of biomaterial 
properties alone is insufficient to effectively regenerate functional cartilage tissue, and 
that the controlled release of stimulatory growth factors that can provide molecular 
signals will be necessary to effectively regenerate cartilage tissue. 
 
Physiologically, cartilage development is regulated by an array of growth factors, 
especially insulin-like growth factor-1 (IGF-1), transforming growth factor-beta 1 
(TGFß1), and basic fibroblast growth factor (bFGF) [261]. The utility of administering 
these growth factors to stimulate repair of cartilage defects is evidence of their 
importance in regulating cartilage growth [214, 262]. However, scaffolds are required to 
deliver and maintain cells and growth factor delivery at the site of a defect. The 
combination of promising biomaterials that support chondrogenesis with systems that 
control the release of stimulatory growth factors may achieve synergistic results.  
 
IGF-1 is pivotal in regulating cell proliferation and differentiation, as well as matrix 
synthesis [200], and its administration has been used to increase proteoglycan and type II 
collagen synthesis in cartilage tissue engineering systems [263]. The chemotactic effects 
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of IGF-1 are also well-known, and may encourage chondrocytes to migrate through a 
scaffold [226, 264]. Sustained, local release of IGF-1 is desirable because of its ability to 
enhance healing of cartilage, and its delivery must be targeted or localized, since it can 
have a wide spectrum of effects in the body [200]. The combination of controlled growth 
factor release with a biomaterial that could be immediately implanted into a cartilage 
defect may achieve functional repair of a cartilage defect.  
 
In this work, IGF-1 was loaded into the degradable PLGA microparticle phase of the 
hydrogels through a novel, direct-incorporation method. The technique is based on a 
double emulsion method of microparticle formation, in which the external aqueous phase 
is the hydrogel solution, so that the PLGA microparticles are directly formed in and 
dispersed throughout PVA hydrogels. The effects of local, controlled release of IGF-1 on 
cartilage formation by chondrocytes seeded in a well-characterized, PGA fiber scaffold 
[107, 265, 266] were examined in subcutaneous implantation in a nude mouse model. 
 
8.2. Methods 
 
8.2.1. Single-step preparation of porous PVA hydrogels containing IGF-1-loaded PLGA 
microparticles  
 
Hydrogels with an initial dry composition of 60wt% PLGA microparticles loaded with 
IGF-1 were prepared in a single step using a modification of the Direct Incorporation 
method described in Specific Aim 1. Recombinant human IGF-1 (Peprotech, Rocky Hill, 
NJ) was dissolved in 10mM acetic acid and 0.1% bovine serum albumin (Sigma Aldrich) 
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at concentrations of 0µg/ml (no dose), 100µg/ml (low dose), and 900µg/ml (high dose). 
One milliliter of the IGF-1 solution was added to an organic phase of 42.9% 50:50 PLGA 
(DL4A) in DCM. This emulsion was sonicated for 5 minutes and then added dropwise to 
a 10% solution of PVA and PVP in the ratio of 99:1 PVA:PVP, as described in Specific 
aim 1, so that the volume of DCM was 35vol% of the entire mixture. These 
concentrations were based on the formulation that was most successful in Specific Aim 4. 
This emulsion was stirred for ten minutes, poured into tubes, and frozen in an acetone/dry 
ice bath, before being exposed to two cycles of freezing at -20°C for 21 hours and 
thawing at room temperature for 3 hours. The hydrogels were then sliced into cylinders 
that were approximately 15mm in diameter and 2mm in height, dehydrated through an 
ethanol series, and dried by critical point drying.  
 
8.2.2. Characterization of hydrogel structure and IGF-1 loading and release 
 
Dry hydrogels (n=3), each about 100mg, were immersed in PBS at 37°C for 3 days and 
then analyzed using wet mode ESEM at an accelerating voltage of 20kV. The diameters 
of PLGA microparticles (n=100) were measured using the public domain ImageJ 
program. Hydrogels (n=2) were also examined after 61 days of immersion in PBS at 
37°C, when the PBS was replaced with fresh medium every two days. 
 
To characterize the release of IGF-1 in vitro, hydrogels (n=3) of no, low, or high dose 
were immersed in 4ml PBS in a shaking waterbath at 37°C. The release medium was 
replaced every two days for 46 days with fresh medium, and samples were analyzed for 
158  
 
concentration of IGF-1 using an enzyme-linked immunosorbent assay (ELISA, R&D 
Systems, Minneapolis, MN). 
 
8.2.3. Chondrocyte seeding and in vivo studies 
 
In order to determine the effects of the local and controlled release of IGF-1 on cartilage 
formation, without the effects of the hydrogel properties, each hydrogel was surrounded 
with 30mg of unwoven PGA fibers (Albany International Research, Albany, NY). These 
fibrous PGA scaffolds were tightly secured to the hydrogels by wetting in a solution of 
2% poly(lactic acid) in DCM and pressing inside a 1-ml syringe overnight, according to 
previously described methods of fabrication of PGA scaffolds that have been shown to 
support the formation of engineered cartilage [107]. Hydrogels, surrounded by a PGA 
scaffold layer, were sterilized by soaking in 70% ethanol and then washed 3 times with 
PBS.  
 
These experiments were conducted in the Shanghai Key Tissue Engineering Laboratory. 
An institutional review committee of Shanghai Jiao Tong University School of Medicine 
approved all animal study protocols. Immature chondrocytes were isolated from cartilage 
explants taken from the knee joints of a 2 week-old piglet through collagenase digestion 
and subsequent cell-straining. Ten million chondrocytes in 200µl of cell culture medium 
(DMEM containing 10% fetal bovine serum, 4.5g/L glucose, 10mM sodium pyruvate, 
25mM HEPES buffer, and 1% antibiotic/antimycotic solution, Invitrogen, Carlsbad, CA) 
were added to each sample by seeding in the PGA scaffold layer surrounding each 
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hydrogel. The cell-seeded constructs were cultured in 10ml medium for 1 week in an 
incubator maintained at 37°C and 5% CO2 and then implanted subcutaneously into the 
backs of nude mice. A sample from each of the four groups (no dose, low dose, high 
dose, and non-cell seeded control with no IGF-1) was implanted into each mouse to 
eliminate inter-animal differences (n=10 per group). 
 
8.2.4. Histological characterization of tissue-hydrogel constructs 
 
The cartilage-hydrogel constructs were removed after 6 weeks in vivo. The fibrous 
capsules surrounding the constructs were removed, and the samples were analyzed by 
gross observation and weighed. Four samples from each group were fixed in 4% 
paraformaledehyde for 3 days at 4°C, embedded in paraffin, and sectioned to 5µm. 
Sections were stained with hematoxylin and eosin for overall structure and with 
Safranin’O and hematoxylin to visualize sulfated proteoglycans. Sections were also 
stained immunohistochemically for the presence of collagen of both type II and type . 
Sections were incubated in mouse-anti-human type II collagen primary antibody, 
followed by goat-anti-mouse secondary antibody, and the color was developed using 3,3-
diaminobenzidine (DAB). Sections were also stained with Alizarin red to visualize 
calcification and with von Kossa staining for mineralization. 
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8.2.5. Mechanical testing 
 
The cartilage-hydrogel constructs (n=6) were tested in uniaxial, unconfined compression, 
using an Instron 50N load cell in a bath of PBS. The samples, which were about 12mm in 
diameter and 3-6mm in height, were pre-loaded to a strain of 10% and compressed 
further to 16% strain at a rate of 100% strain/minute. The slope of the linear stress-strain 
curve was defined as the compressive modulus.  
 
8.2.6. Biochemical assays 
 
After mechanical testing, cartilage-hydrogel constructs (n=6) were minced, dehydrated 
by lyophilization, and digested in papain solution overnight at 65°C.  The papain solution 
was 125µg/ml papain 10mM HCl, 10mM L-cysteine, 0.1M sodium acetate, and 0.05M 
ethylenediaminetetraacetic acid (Sigma-Aldrich). The total content of 
glycosaminoglycans (GAGs) was determined by reaction by dimethylmethylene blue 
dye, using shark chondroitin sulfate (Sigma-Aldrich) to generate a standard curve [267]. 
The total content of collagen was calculated using an orthohydroxyproline assay, which 
measures approximately 10% of the total collagen [268]. The wet weights of the tissue 
portion of the constructs were calculated by subtracting the mass of the non-cell-seeded 
control from those of the cartilage-hydrogel constructs. The DNA content in the 
constructs was determined using the Picogreen assay (Invitrogen) and converted to 
number of chondrocytes using the conversion factor of 7.7pg of DNA per chondrocyte 
[260]. GAG and collagen contents were compared to those of healthy cartilage obtained 
from the knee joints of an immature piglet. 
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8.2.7. Statistical analysis 
 
All data points are represented as the mean ± one standard deviation. Statistical 
significance was determined by one way analysis of variance (ANOVA) with post-hoc 
analysis by Tukey’s test. P-values less than 0.05 were considered statistically significant. 
 
8.3. Results & Discussion 
8.3.1. Single-step preparation of IGF-1-loaded PLGA microparticles embedded 
throughout PVA hydrogels  
 
In this study, IGF-1 was encapsulated in PLGA microparticles and embedded in PVA 
hydrogels in one step, using the Direct Incorporation method, which has been shown to 
allow a high level of control over the composition, structure, porosity, swelling behavior, 
and mechanical properties of the hydrogels. PLGA microparticles with average diameters 
of 11.3±6.42µm formed in PVA hydrogels through a novel, single-step method based on 
a double emulsion, in which the hydrogel solution was the external aqueous phase (Fig. 
8.1, arrows). The microparticles were homogenously dispersed throughout the hydrogels 
(Fig. 8.1a), and showed little signs of degradation after 61 days in PBS (Fig. 8.1b).  
 
8.3.2. Sustained release of IGF-1 from hydrogels 
 
Release of IGF-1 from the hydrogels was detected over 32 days for hydrogels loaded 
with the low dose (Fig. 8.2) and over 46 days for hydrogels loaded with the high dose 
(Fig. 8.3), although the experiment was terminated at this time and it is possible that more 
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protein could be released later. The kinetics of IGF-1 release from the hydrogels were 
unaffected by the initial loading. Release of IGF-1 from hydrogels was described by an 
initial burst during the first day of 86.91 ± 66.60 and 2284.6 ± 660.8ng, which was 
2.6±2.0% and 7.6±2.2% of the theoretical protein loading, for the low and high dose, 
respectively (Fig. 8.4). These amounts correspond to the protein that was loaded in the 
hydrogel phase, as opposed to encapsulation within the PLGA microparticles, and are 
consistent with typically fast release behavior from hydrogels [269, 270]. The protein 
release continues at a constant rate for the next 10 days, corresponding to the protein 
electrostatically adsorbed to the surfaces and/or diffusing through the micropores of the 
PLGA microparticles [271], and the release is tempered by encapsulation in the 
hydrogels [220, 223]. The hydrogels continue to release detectable amounts of protein for 
over 32 days for the low dose and for over 46 days for the high dose, in which the release 
rate is about 10ng/day from day 20 to day 46 (Fig. 8.3 insert). The release behavior in this 
phase corresponds to diffusion of the protein through pores, which increase in size as the 
microparticles degrade [271]. 
 
After 46 days, the hydrogels loaded with the high dose of IGF-1 released about 26% of 
the initial load, which was about 30µg IGF-1 per hydrogel, and the hydrogels loaded with 
the low dose released about 13% of their initial load, which was 3.3µg IGF-1 per 
hydrogel (Fig. 8.4). Although it is possible that more protein would be released after 46 
days, it is also possible that much of the protein was degraded due to contact with the 
organic solvent during hydrogel fabrication. 
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8.3.3. Effects of controlled release of IGF-1 on cartilage tissue formation and integration 
with hydrogels 
 
The cell-seeded hydrogels were cultured for one week in vitro before subcutaneous 
implantation into nude mice for 6 weeks. Differences in tissue formation in the different 
groups were immediately apparent upon harvest of the samples. The hydrogels were 
surrounded by layers of cartilage, and hydrogels that released IGF-1 of either the low or 
the high dose were surrounded by thicker layers of cartilage than the hydrogels without 
IGF-1 (Fig. 8.5). There were no signs of residual PGA fibers surrounding any of the 
hydrogels. The level of integration between the neocartilage layers and the hydrogels 
depended on the dose of IGF-1. The cartilage layers surrounding hydrogels without IGF-
1 were thin and completely separate from the hydrogels. The cartilage layers surrounding 
hydrogels with the low dose of IGF-1 were somewhat attached to the hydrogels, with 
some areas of separation. Cartilage layers surrounding hydrogels loaded with the high 
dose of IGF-1 were completely attached to the hydrogels. Pockets of ossification were 
also visible upon gross examination (Fig. 8.5 arrows), and the amount of mineralized 
tissue appeared to increase with the dose of IGF-1, although there was some 
mineralization in the tissue surrounding hydrogels without IGF-1.  
 
Histological analysis using Safranin’O to visualize the presence of sulfated proteoglycans 
revealed a more detailed view of the cartilage structure. The cartilage layers around 
hydrogels without IGF-1 were thin and did not completely surround the hydrogels (Fig. 
8.6a). There were some small pockets of calcification (Fig. 8.6b), but also areas of mature 
cartilage tissue, with chondrocytes surrounded by lacunae (Fig. 8.6c). The layers of 
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cartilage surrounding hydrogels loaded with either dose of IGF-1 were thicker than those 
surrounding hydrogels with no IGF-1 (Fig. 8.6d and g), but also had larger areas of 
calcification (Fig. 8.6e and h). 
 
Sample processing conditions caused the hydrogels to shrink to a greater extent than the 
surrounding cartilage, making analysis of integration difficult. However, areas of tight 
integration between cartilage layers and hydrogels remained for those loaded with either 
the low or high dose of IGF-1. Areas of integration were much more pronounced for 
hydrogels loaded with the high dose, although tissue did not appear to penetrate into the 
hydrogel, probably because of insufficient hydrogel porosity (Fig. 8.6i). Evidence of 
integration was not seen for hydrogels without IGF-1, confirming results seen upon gross 
observation (Fig. 8.6b). IGF-1 is a chemoattractant for chondrocytes and stimulates them 
to migrate towards a concentration gradient [226, 264]. The tight integration of the 
cartilage layers with hydrogels releasing IGF-1 may be a result of chondrocytes migrating 
towards the concentration gradient of IGF-1. This enhancement of integration would be 
extremely beneficial for the implantation of the hydrogels into cartilage defects. The 
chondrocytes of the surrounding tissue must then be both migratory and proliferative, 
properties that can be induced by partial enzymatic digestion [198]. 
 
8.3.4. Ectopic calcification with increasing concentration of IGF-1 
 
Samples in all groups stained strongly for the presence of type II collagen (Fig. 8.7a, b, 
and c), with areas of mature cartilage containing chondrocytes surrounded by lacunae 
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(Fig. 8.7c, f, and i). Areas of the cartilage layers nearer to the hydrogels stained darker for 
collagen II for hydrogels releasing IGF-1, and no such gradient was observed for 
hydrogels without IGF-1 (Fig. 8.7a, b, and c).  
 
Each sample also had areas of irregular tissue formation, corresponding to the 
mineralized areas (Fig. 8.7b, e, and h). These mineralized areas stained positively for 
calcium deposits, determined by staining with Alizarin red (Fig. 8.8), and for phosphates, 
determined using von Kossa staining (Fig. 8.9). Hydrogels without IGF-1 did have areas 
of mineralization, but the amount of mineralized tissue increased with increasing dose of 
IGF-1.  
 
Ectopic calcification and mineralization is a common complication in injured tissue and 
in tissue engineered and bioprosthetic grafts [272]. The generation of cellular 
degeneration byproducts by apoptotic cells has been shown to stimulate calcium 
phosphate crystal nucleation in tissues such as heart valves [272, 273]. Apoptotic cells 
were present in the mineralized areas of the cartilage-hydrogel constructs (Fig. 8.6). 
Mechanical stress can also exacerbate mineralization because it damages the structural 
integrity of the tissue [274]. Pockets of mineralized tissue were concentrated at the 
corners of the cartilage-hydrogel constructs, areas of higher mechanical stress, suggesting 
that the unnatural shape of the cartilage layers around the hydrogels contributed to the 
onset of calcification (Fig. 8.6, 8.8, 8.9). The subsequent invasion of host capillaries from 
the surrounding mouse would stimulate chondrocyte hypertrophy, apoptosis, and 
subsequent osteogenesis and mineralization through the natural developmental process of 
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endochondral ossfication [35]. In addition, programmed cell death of chondrocytes 
initiates mineralization in developing bone [275]. This behavior would be augmented by 
the stimulatory growth factor IGF-1 [276, 277], explaining the dose-dependent behavior 
observed in this study (Fig. 8.8, 8.9). These results indicate that biomaterials should be 
designed that limit abnormal mechanical stress on the tissue. 
 
Chondrocytes do retain the ability to undergo hypertrophy and differentiate towards the 
bone lineage, but when implanted subcutaneously they have been shown to form stable 
cartilage that is resistant to hypertrophy or vascular invasion [278, 279]. In contrast, 
mesenchymal stem cells (MSCs), exposed to chondrogenic medium and then implanted 
subcutaneously, do have the tendency to form cartilage that undergoes hypertrophy and 
calcification [278]. Circulating MSCs in the subcutaneous space of the mouse may have 
infiltrated the constructs and differentiated into chondrocytes that underwent hypertrophy 
and calcified. IGF-1 is chemoattractive and can recruit circulating MSCs [227, 280], so 
more MSCs would be attracted to materials releasing higher concentrations, resulting in 
larger areas of mineralized tissue. This mechanism is considered less likely because of 
the presence of calcification in cartilage surrounding hydrogels without IGF-1. Ongoing 
studies to determine the source of the cells found in the mineralized areas of these tissue-
engineered constructs will show if the mechanism of ectopic calcification is due to a 
typical response to ‘injured’ tissue or to the infiltration of circulating host MSCs. Since 
tissue injury naturally recruits circulating stem cells [281, 282], the dystrophic 
ossification may also be a combination of the two mechanisms. 
 
167  
 
8.3.5. Dose-independent increases in markers of cartilage formation 
 
The total content of glycosaminoglycans (GAGs) and collagen in the cartilage tissue 
surrounding hydrogels loaded with either dose of IGF-1 were higher than for hydrogels 
without IGF-1, although there were no differences between the low and high doses (Table 
8.1). This trend was also observed when the GAG and collagen contents were normalized 
to the number of cells. When these values were normalized to the wet weight of the 
tissue, there were no differences between any of the samples in terms of GAG content, 
but cartilage surrounding hydrogels with the low and high dose of IGF-1 did contain 
more collagen per gram of tissue. These normalized GAG and collagen contents were not 
statistically different from immature porcine cartilage tissue, a result not typical of 
engineered cartilage, suggesting that controlled release of IGF-1 stimulates the formation 
of healthy cartilage tissue. 
 
The compressive moduli of the cartilage-hydrogels constructs were higher for hydrogels 
containing IGF-1 than those without, indicating contribution from the cartilage to the 
mechanical properties (Fig. 8.10). There was no difference in mechanical properties 
between hydrogels loaded with the low and high doses of IGF-1, corresponding to their 
similar ECM contents. The compressive moduli of these constructs approached that of 
healthy, mature cartilage tissue, which is about 0.4-0.8 MPa [58]. The cartilage-hydrogel 
constructs without IGF-1 were only slightly stiffer than the non-cell-seeded control, 
indicating that the cartilage layers did not significantly contribute to the mechanical 
properties.  
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The controlled release of IGF-1 from these hydrogels enhanced cartilage formation in the 
PGA fiber scaffolds surrounding the hydrogels, resulting in tissue with similar structure 
and extracellular matrix composition to healthy cartilage. Integration between these 
cartilage layers and the hydrogels was also increased with dose of IGF-1, which has 
exciting implications for their clinical application. Surprisingly, there were no differences 
in biochemical or mechanical properties between the cartilage that formed around 
hydrogels loaded with the low and high doses, despite an order of magnitude difference 
in concentration. About 300ng of IGF-1 were released from the hydrogels loaded with the 
low dose over the first 7 days, during which time the cell-seeded hydrogel constructs 
were incubated in vitro and so the concentration may be diluted, and only 100ng was 
released at a rate of less than 1ng/day from day 20 to day 38. Hydrogels loaded with the 
high dose of IGF-1 released 4500ng in the first 7 days and about 10ng/day from day 20 to 
day 46. A lack of IGF-1 dose-responsiveness was also observed in other studies of 
cartilage engineered on PGA fiber mesh scaffolds, and is attributed to the production of 
maximally high levels of extracellular matrix by chondrocytes in high cell densities 
[283]. The effectiveness of the concentrations may also be enhanced because the protein 
is released directly to the cartilage layers, which would limit further diffusion. A lower 
therapeutic dose is advantageous for manufacturability. The fact that biochemical 
markers of cartilage formation were not different for hydrogels loaded with the low and 
high doses also suggests that the integration of the neocartilage layers and the hydrogels 
was the result of chondrocytes migrating towards the concentration gradient of IGF-1, as 
opposed to the simple production of greater amounts of extracellular matrix. Integration 
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was enhanced with the higher dose of IGF-1, however, so the higher dose may be 
required to influence integration. 
 
Subcutaneous implantation in the athymic mouse, immunocompromised due to T cell 
deficiency and impaired T and B cell function [284], is a good model for preliminary 
analysis of controlled release systems for tissue engineering applications. Release in the 
subcutaneous space more closely matches the intended environment than in vitro cell 
culture, in which concentration gradients are established by refreshing the media. In 
addition, the animals’ immune deficiency permits the implantation of cells from another 
species, so that biomaterial properties can be evaluated without the compounding effects 
of the immune system. By wrapping PGA fiber scaffolds around the hydrogels, the 
effects of controlled release of IGF-1 could be studied separately from the hydrogel 
properties. However, the unnatural structure of the cartilage that formed in this model, a 
capsule surrounding the hydrogel, may have led to calcification. In addition, the lack of 
cartilage-specific mechanical loading is a significant discrepancy from the physiological 
environment of a cartilage implant. The vascular environment surrounding the implants is 
also not found in cartilage, and vascular invasion from the host is an effect that would not 
happen in cartilage. 
 
In summary, this study showed the value of the controlled and sustained release of IGF-1 
for cartilage tissue engineering in a biodegradable PGA fiber scaffold. However, in order 
to fully take advantage of this technology, the porosity of the hydrogels must be 
increased to allow surrounding chondrocytes to infiltrate and strengthen the interface. 
170  
 
Engineered cartilage integrates well with surrounding tissue, so a hybrid cartilage-
hydrogel construct is expected to integrate better than PVA hydrogels, and the 
concentration gradient of IGF-1 from the hydrogels towards the surrounding tissue may 
also enhance integration with surrounding tissue. Lower doses of IGF-1 must be studied 
to determine the actual therapeutic dose necessary to enhance cartilage formation and 
integration. 
 
8.4. Conclusions 
 
This study showed that growth factor loaded microparticles could be incorporated into 
PVA hydrogels in a simple step that also imparts a high degree of porosity. The release of 
IGF-1 depended on the dose, and was sustained over 6 weeks in vitro. This controlled 
release enhanced cartilage formation in scaffolds implanted subcutaneously into athymic 
mice, and enhanced cartilage-hydrogel integration, which is a significant problem for 
hydrogel implants. Further studies are required to determine the precise dose of IGF-1 
required for enhancement of cartilage formation within the pores of the hydrogels. 
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Table 8.1: Biochemical analysis of cartilage-hydrogel constructs (n=6, *p<0.05 compared 
to hydrogels without IGF-1). 
 
Dose of 
IGF1 
Total 
GAGs 
(mg) 
GAGs per 
cell 
(mg/cell) 
GAGs per 
wet 
weight 
(mg/g) 
Total 
Collagen 
(mg) 
Collagen 
per cell 
(mg/cell) 
Collagen 
per wet 
weight 
(mg/g) 
None 4.19±1.06 0.33±0.16 16.4±2.57 8.78±1.78 0.68±0.27 35.3±9.08 
Low 6.23±1.29* 0.61±0.38* 15.7±4.29 18.3±2.45* 1.78±1.00* 46.0±9.63 
High 7.17±1.52* 0.52±0.08* 15.8±3.10 21.5±1.96* 1.57±0.22* 48.0±8.55 
Cartilage -- -- 25.6±12.5 -- -- 37.2±21.4 
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Figure 8.1: ESEM images of PLGA microparticles dispersed throughout PVA hydrogels 
after (a) 3 days and (b) 61 days in PBS at 37ºC. Representative microparticles indicated 
by arrows. Original magnification is 350x. 
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Figure 8.2. Cumulative IGF-1 release from hydrogels loaded with the low dose. Error 
bars represent ± one standard deviation, and those that are not visible are smaller than the 
data point (n=3). 
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Figure 8.3. Cumulative IGF-1 release from hydrogels loaded with the high dose. Error 
bars represent ± one standard deviation, and those that are not visible are smaller than the 
data point (n=3). 
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Figure 8.4. Release as a fraction of initial loading. Error bars represent ± one standard 
deviation, and those that are not visible are smaller than the data point (n=3). 
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Figure 8.5. Gross view of cross-sections of cartilage-hydrogel constructs after 
subcutaneous implantation for 6 weeks. (a) Non-cell-seeded control, (b) hydrogels 
without IGF-1, (c) hydrogels with the low dose of IGF-1, and (d) hydrogels with the high 
dose of IGF-1. Arrows point to areas of calcification. 
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Figure 8.6. Histological analysis of cross-sections of cartilage-hydrogel constructs, using 
Safranin’O (proteoglycans, red) and hematoxylin (cell nuclei, blue). The hydrogels, 
stained light purple from the hematoxylin, were surrounded by cartilage tissue, stained 
red by Safranin’O. The hydrogels shrank during sample processing. (a-c) Hydrogels with 
no IGF-1; (d-f) hydrogels with the low dose of IGF-1; (g-i) hydrogels with the high dose 
of IGF-1. All scale bars are 500µm. Original magnfications: a, d, g: 10x; b, e, h: 40x; c, f, 
i: 100x). 
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Figure 8.7. Immunohistological staining for the presence of type II collagen (brown). (a-
c) Hydrogels with no IGF-1; (d-f) hydrogels with the low dose of IGF-1; (g-i) hydrogels 
with the high dose of IGF-1. All scale bars are 500µm. Original magnifications: a, d, g: 
10x; b, e, h: 40x; c, f, i: 100x). 
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Figure 8.8. Histological analysis using Alizarin red, which stains calcium deposits red. 
Original magnifications are 50x (12.5x for inserts). All scale bars are 1mm. 
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Figure 8.9. Histological analysis using von Kossa staining, which stains phosphate groups 
brown. Original magnifications are 50x (12.5x for inserts). All scale bars are 1mm. 
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Figure 8.10. Compressive moduli of cartilage-hydrogel constructs, determined in 
uniaxial, unconfined compression (n=6, *p<0.05). 
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Chapter 9: Conclusions and Recommendations for Future Work 
9.1. Conclusions 
 
I aimed to combine the integrative advantages of PGA scaffolds with the mechanical 
advantages of PVA hydrogels. I designed porous PVA hydrogels such that chondrocytes 
could be seeded throughout the porous network and induced to develop healthy cartilage 
tissue. Since PVA hydrogels are nondegradable, the result was a hybrid hydrogel-
cartilage construct that may integrate well with surrounding tissue. Moreover, the 
nondegradable nature of the PVA hydrogel would prevent the mechanical properties from 
diminishing over time, as is the case with degradable scaffolds. These superporous, semi-
degradable hydrogels were evaluated as cartilage replacement materials in terms of their 
dynamic structure, mechanical properties, and swelling properties, over the course of 
swelling in model osmotically-conditioned systems. The hydrogels were then 
characterized for their ability to support cartilage formation by encapsulated cells and the 
effects of controlled release of growth factors to enhance cartilage formation and 
integration between the hydrogels and the surrounding tissue. 
 
Through the simple addition of poly(lactic-co-glycolic acid) (PLGA) microparticles using 
a novel technique based on a double emulsion, a high degree of porosity as well as cell 
adhesiveness were imparted to the PVA hydrogels, which were crosslinked using freeze-
thaw cycling. The porosity is a result of crosslinking of the hydrogel solution around the 
organic solvent, and increased cell adhesiveness is due to the high levels of cell 
attachment to PLGA. The porosity, pore size, and swelling properties of the hydrogels 
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could be precisely controlled by varying initial processing parameters, such as the 
molecular weight and amount of PLGA, the type and volume of organic solvent used in 
the PLGA solution, the initial freezing temperature and the stirring speed. For example, 
decreasing the PLGA content and increasing the solvent content increased porosity, 
average pore size, and swelling ratio. Porosity values ranged from 65 to 85%, and 
average pore sizes ranged from 60 to 100µm. 
 
To ensure that this addition of PLGA and porosity did not negatively impact the 
mechanical properties, the hydrogels were tested in uniaxial, confined creep compression. 
Like cartilage, the behavior of the hydrogels was well-described by the biphasic theory, 
which models the mechanical behavior as fluid flowing through a solid, elastic matrix.  
However, the aggregate modulus was significantly reduced with the introduction of high 
levels of porosity, resulting in values that were about half that of healthy cartilage. 
Importantly, values of permeability and creep time constants, which describe the fluid 
flow behavior, were similar to healthy cartilage, suggesting that increasing the stiffness of 
the solid matrix would compensate for the decreases in aggregate modulus resulting from 
high levels of porosity. 
 
The next step was to characterize the swelling behavior of the porous hydrogels in 
solutions that were conditioned to have the same osmotic pressure as cartilage. 
Phosphate-buffered saline (PBS) is the most commonly chosen swelling medium to 
model hydrogel behavior in articular cartilage. However, the use of PBS does not fully 
elucidate the osmotic pressure hydrogels will face in many tissues in vivo. PBS solutions 
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were osmotically conditioned through the addition of poly(ethylene glycol) (PEG), and 
validated by comparing the swelling behavior of hydrogels in these solutions to that in 
cartilage explants. When hydrogels were implanted ex vivo into bovine cartilage, their 
swelling ratios, water contents, and porosities significantly decreased. This response was 
matched by hydrogels immersed in a solution of PEG having an osmotic pressure 
matching articular cartilage. The hydrogels were further characterized over 6 weeks in 
PEG and in PBS, with each system having unique affects on the hydrogel swelling 
behavior and material properties. The controlled degradation of the PLGA phase reflected 
the dynamic nature of native tissues and allowed for the assessment of hydrogel swelling 
characteristics under fluctuating osmotic pressures. The results show that a PEG solution 
conditioned to an osmotic pressure of cartilage is a strong model for the effects of the 
osmotic environment on hydrogels and that PBS is an ineffective predictor of swelling 
changes in vivo. Characterization of the swelling behavior in a model osmotic 
environment is an important test to evaluate biomaterial properties.   
 
Once the porous structure, mechanical properties, and swelling properties of the 
hydrogels were optimized, they were evaluated for their ability to support cartilage 
formation within them and integration with surrounding cartilage tissue if they were to be 
implanted into a defect. The efficiency of seeding chondrocytes in these hydrogels 
increased with increasing PLGA content, and was practically zero for control hydrogels 
that did not contain PLGA. Most importantly, the degree of cartilage formation after 7 
weeks in vitro, assessed by histological analysis, was proportional to the PLGA content.  
Cartilage-like tissue filled the pores of the hydrogel network, confirming that it is 
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possible to create a hybrid hydrogel-cartilage construct. In contrast, chondrogenesis was 
nonexistent in hydrogels prepared without PLGA. These results were not unexpected, 
because cells attach to PVA hydrogels at very low levels, and some cell adhesion is 
required for chondrogenesis. Though the hydrogels were initially weaker than articular 
cartilage, swelling in cell culture media caused significant increases in mechanical 
properties so that they were not different from cartilage, because of the increase in 
swelling pressure resulting from the degradation of the PLGA phase into smaller acidic 
byproducts.   
 
Finally, the ability of the hydrogels to integrate with surrounding tissue was characterized 
by wrapping the hydrogels in PGA fibers that were seeded with chondrocytes. This 
method would simulate implantation into a defect surrounded by tissue containing 
proliferative cells, a condition that can be created by partial enzymatic treatment.  
Insulin-like growth factor-1 (IGF-1) was incorporated into the PLGA microparticles 
within the PVA hydrogels, to create a chemoattractive gradient towards which 
surrounding chondrocytes would migrate. The PLGA microparticles degraded 
hydrolytically over time in physiological conditions, releasing the growth factor at a 
controlled rate. The release profile could be adjusted by changing the loading, and was 
controlled for over 38 days in vitro, with a minimal burst release. Hydrogels were loaded 
with a high dose (2.7µg/ hydrogel), a low dose (0.33 µg/ hydrogel), and no IGF-1, and 
implanted subcutaneously into nude mice for 6 weeks. After 6 weeks in vivo, thick layers 
of cartilage grew in the PGA fiber layer surrounding the hydrogels. The cartilage layers 
were tightly integrated with hydrogels loaded with the high dose of IGF-1, slightly 
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integrated with hydrogels loaded with the low dose, and not integrated at all with 
hydrogels containing no IGF-1. The amount of cartilage formation, determined by 
measuring glycosaminoglycan and collagen content and by histological analysis, was 
much higher for hydrogels containing either dose of IGF-1 than the control hydrogels.  
The contents of these markers of cartilage-specific extracellular matrix were not different 
from healthy cartilage.  Interestingly, there were no differences in cartilage formation for 
hydrogels prepared with a low or high dose of IGF-1, despite an almost 10-fold increase 
in dose. These results indicate that the release of IGF-1 from the hydrogels could 
simultaneously enhance cartilage formation and integration with surrounding tissue. 
 
9.2. Recommendations 
 
This work has exciting implications for the application of PVA hydrogels for cartilage 
repair. Future work should fine-tune the properties of these hydrogels so that they behave 
more closely to cartilage in physiologically relevant tests, with respect to their 
mechanical properties, frictional properties, and integration with surrounding tissue. The 
PVA-PLGA hydrogels should be also loaded with the appropriate growth factors to 
promote the chondrogenic differentiation of mesenchymal stem cells, a more clinically 
relevant cell source than chondrocytes since they can be isolated from bone marrow, and 
the subsequent formation of cartilage in the pores of the hydrogel.  
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An important aspect of cartilage function that is often overlooked in cartilage tissue 
engineering is lubrication. PVA hydrogels prepared by freezing and thawing have been 
shown to have similar frictional and lubricating behavior to articular cartilage, directing 
fluid to contact surfaces according to the ‘squeeze-film’ lubrication model under low 
loads and the ‘boundary’ lubrication model under high loads [60, 182]. Therefore, it is 
expected that the cartilage-hydrogel constructs will have similar tribological properties to 
normal cartilage. However, if necessary, the coefficient of friction should be reduced 
through the addition of lubricating proteins such as hyaluronic acid and lubricin to the 
surface. 
 
Finally, the integration of the hydrogels with surrounding tissue must be analyzed in an 
explant model. It is expected that a critical concentration of cells and growth factors will 
be required for successful integration.  
 
PVA hydrogels have very similar mechanical, fluid flow, tribological, and swelling 
properties to articular cartilage. With the inclusion of one or more cell types as well as 
controlled release systems, these hydrogels can also be used to study the specific effects 
of various stimuli, such as mechanical loading and growth factors, on cell response. 
When the mechanical, lubricating, and integrative properties of the hydrogels are 
optimized in vitro, we can then confidently proceed with pre-clinical studies. 
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